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1 MAGNESIUM 
1.1 Introduction 
Magnesium (Mg) probably derives its name from Magnesia, Мάγνήσιά , which 
is a prefecture in Thessaly, Greece were it was first found and to this present 
day a lot of magnesium ore is present in the area.1,2 The first evidence of Mg in 
the history of medicine dates back to 1695 when N. Grew separated the solid 
salt Magnesium Sulfate from the Epsom spring water. This latter was a 
commonly used remedy in the 16th century known for its healing properties. 3 
Later on, in 1755 Joseph Black recognized Mg as an element and after about fifty 
years Sir Humphrey Davy isolated pure magnesium.4  
Classified as alkaline earth element, Mg has an atomic number of 12 and is 
present in three stable isotopes 24Mg, 25Mg, 26Mg but we usually refer to the 
24Mg, which is the most common isotope with a percentage of 78.99%.1,5 
Mg2+ , which virtually always exhibits a +2 oxidation state because of the loss or 
sharing of its two 3s electrons, is the 8th most abundant element in the earth in 
the form of solid salts; furthermore, it is the most abundant divalent cation in 
the cells. Since many magnesium salts are highly soluble in water, this cation 
presents a high bioavailability for the cells. Due to its unique physical and 
chemical properties and its abundance in the intracellular environment, Mg2+ 
participates in a host of biological processes and can be ascribed to the so-called 
essential elements for human life.6,7 The National Institute of Health recommend 
a daily Mg2+ intake of 420 mg for men and 320 mg for women.8 Indeed, Mg2+ 
deficiency has been associated with a wide range of diseases including diabetes 
mellitus type 2, hypertension, migraine and depression. 5,9,10 
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1.2 Magnesium ion channels and transporters 
The majority of eukaryotic cells tend to ensure that the magnesium 
concentration in the cell remains unchanged even when a major trans-
membrane gradient is artificially imposed. For example, different hormones are 
able to induce the movement of large amounts of total Mg2+ in either directions 
across eukaryotic cells membranes whereas relatively slight variations occur in 
free intracellular Mg2+.11,12,13 This indicates the ability of the cell to tightly 
regulate intracellular Mg2+ content by precise control mechanisms at the level of 
entry, efflux, intracellular buffering and compartmentalization. Although these 
Mg2+ intracellular variations are small, they could alter Mg2+ levels in cell 
organelles profoundly influencing signalling pathways that regulate cellular 
functions.14,15,16 Mitochondria are the most affected organelles with important 
repercussions on cellular bioenergetics.17 
As previously stated, Mg2+ deficiency was found to be associated to several 
diseases such as hypertension, eclampsia and cystic fibrosis. Therefore, the 
regulation of cellular Mg2+ homeostasis is critical for numerous cellular 
functions and has high clinical relevance.18 
Being the second most abundant cellular divalent cation, Mg2+ handling in the 
cell is usually maintained in the range of 10-30 mM. However, since most of the 
intracellular Mg2+ is bound to macromolecules the concentrations of freely 
available Mg2+ falls within the low millimolar range 0.2-1.2 mM.19,20 Mg2+ 
intracellular levels are regulated by the activity of many powerful cations 
transporters localized in the cell membrane surface as well as in the membrane 
of cellular organelles.17 Amongst cellular organelles mitochondria represent the 
major Mg2+ intracellular pools.21,22 Circumstantial evidences, suggest that Mg2+ 
can be mobilized from mitochondria under various conditions including 
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hormonal stimuli and that part of the observed variations in mitochondrial 
magnesium is related to the control of respiration.15,23,24 
Magnesium transport can be driven by channels, which allow accumulation, or 
exchange mechanisms, which allow extrusion.17,25 Table I reports the main Mg2+ 
transporters in eukaryotic cells. 
Aside the two mechanisms favouring the entry of Mg2+ into mitochondria and 
Golgi, all the other influx transporters are located at the cell membrane level. 
Channels allowing Mg2+ entry into the cell were firstly described for 
prokaryotes and protozoan.26,27,28 Only recently, several Mg2+ entry mechanisms 
with channels or channels-like features have been identified in eukaryotic cells. 
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Table I   Magnesium transporters in mammalian cells (table adapted from J.de Baaij 2015 and 
A.Romani 2011)5,25 
 
 
 
 
Before listing the main Mg2+ transporters, it is worth mentioning the peculiarity 
of the ionic radius of Mg2+ and its coordination geometry.1,29 Mg2+ has the largest 
radius of all cations when hydrated, but is among the smallest when 
dehydrated with a 400-fold increase in volume.30 Moreover, the Mg2+ ion is 
almost invariably hexacoordinated and maintains strict bond lengths and bond 
angles (2.15+-0.1A and 90° respectively). It also binds the hydrating waters 
stronger than other cations like sodium, potassium and calcium; this feature   
leading to the postulation that activity of magnesium as an enzyme cofactor is 
mediated through spatial coordination of bound water molecules. These 
peculiar properties pinpoint the special role of Mg2+ in catalysis, biological 
Mg 2+  Transporters
Cell localization Protein Family Members Expression Permeability Mechanism
Influx mechanism
Mitochondria memebrane MRS2 Mrs2/AtMrs2,Lpe10 Ubiquitous Mg>Ni Channel
Golgi MMgT MMgT1 Channel
MMgT2
Plasma membrane TRPM TRPM6 Kidney, Intestine Ba>Ni>Mg>Ca Channel
TRPM7 Ubiquitous Ba>Ni>Mg>Ca Channel
Claudins CLDN16 Kidney Channels
CLDN19
MagT1 MagT1 Ubiquitous Mg>Ba>FE=Cu Channel
MgTE SLC41A1 Ubiquitous Mg>Sr>Fe>Ba>Cu Exchanger
SLC41A2 \ Exchanger
SLC41A3
CNNM CNNM1 Brain Cu>Mg? ?
CNNM2 Kidney Mg>Sr>Zn>Cd Transporter?
CNNM3 Ubiquitous Mg>Fe>Cu>Co Transporter?
CNNM4 Intestine Mg Exchanger?
Efflux mechanism
Na+/Mg2+ exchanger Antiport
Na-indipendent Exchanger
H+/Mg exchanger Exchanger
Mn2+/Mg2+ antiporter Exchanger
Ca2+/Mg2+ antiporter Exchanger
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structures and regulation of many cellular processes and must be taken into 
account when studying the binding of Mg2+ to cellular macromolecules.31 In the 
case of macromolecules such as transport proteins, these have to be able to 
recognize the hydrated cation and then to remove the hydration shell to let 
Mg2+ pass through membrane.1 Consequently, this mechanism of transport 
requires a lot of energy.5 Taking all together, these unique features of 
magnesium lead us to believe that the system for magnesium transport should 
be rather unique too.32 
 
  
1.2.1 Exchange mechansims 
Mg2+ extrusion is operate by two kind of exchange mechanisms: the Na+-
dependent and the Na+-independent pathways, but information about their 
operation, abundance and tissue specificity remains largely unknown.17 
The main mechanism, originally proposed by Theodor Gunther in 1984, is 
currently believed to be a Na+-dependent Mg2+ efflux. This notion has been 
supported by a large body of evidence in literature and characterized in many 
cell types. Though the stoichiometry of this exchange is not fully elucidated, it 
has been found that its activation is mediated by cAMP. Indeed, stimulation of 
β-adrenergic, glucagon or administration of forskolin all results in Mg2+ 
extrusion via cAMP mediated phosphorylation of the Na+-dependent 
mechanism. 33,34 
Nevertheless, in the absence of extracellular Na+ to support the Na+/Mg2+ 
exchanger a Na+-independent Mg2+ extrusion pathway has also been shown to 
exist. Although it remains poorly characterized it seems that different cations 
including Ca2+ or Mn2+ or anions such as HCO3- or Cl- are utilized by this 
mechanism. However it remains unclear whether it operates as antiporter for 
cations or sinporter for cations and anions.35 
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1.2.2 CorA family proteins 
CorA proteins is a group of ion transporters that mediate transport of divalent 
metal ions across biological membranes.  
CorA proteins are abundant among the prokaryotic organisms but homologues 
are present in both human and yeast. The activity of CorA proteins has 
generally been associated with the transport of magnesium ions but the 
members of this family can also transport other ions such as cobalt and nickel.32 
This family of proteins present two predicted transmembrane domains, 
separated by short loop-oriented to the outside of the membrane and a 
YGMN/F motif at the end of the N-terminus.18 
The functional homologues characterized in the inner mitochondrial membrane 
of yeast and mammals are the MRS2/LPE10 type, and in the plasma membrane 
of yeast the ALR/MNR type.36,37 
 
1.2.2.1 MRS2 
Whereas CorA proteins mediates Mg2+ influx in most of the prokaryotes, MRS2 
family channels deal magnesium transport in mammals and are the only 
recognized Mg2+ transporter in mitochondria of mammals, yeast and plants.38 In 
eukaryotes, the CorA-like Mrs2 protein was firstly characterized in 
Saccharomyces cerevisiae mitochondria by a genetic screening affecting splicing of 
group II introns.39  
Mrs2 is  a pentameric protein resembling a funnel of ~50 kDa nuclear encoded 
(Fig. 1) which  shares with CorA superfamily proteins  the two TM domain and 
the glycine–methionine–asparagine (GMN) motif which is essential for channel 
function.40 The CorA-like Mrs2 protein, found to localize in mitochondrial inner 
membranes is required for normal mitochondrial Mg2+ homeostasis and 
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function, the stability of mitochondrial respiratory complexes and the 
maintenance of myelination within the central nervous system.41,42 Notably, 
Mrs2 expression is a genetic hallmark of embryonic stem cells.43 Although ion 
selectivity remains unclear despite numerous studies, the conserved GMN 
sequence motif at the end of TM1 α-helix on the outer surface of the membrane 
is considered to be essential for Mg2+ recognition.40,44 
Mrs2 forms a Mg2+ selective, high-conductance channel which controls Mg2+ 
influx into mitochondria. The motor of this Mg2+-influx pathway appears to be 
the mitochondrial membrane potential Δψm. Accordingly, pharmacological 
agents inhibiting the F1-F0 ATP synthase or the ADP/ATP translocase are able 
to modulate Mrs2 activity leading to a substantial decrease of the amplitude 
Mg2+ influx. An elegant experiment conducted on isolated yeast mitochondria 
by Kolisek et al. shows how Mrs2 overexpression induces a marked increase in 
free mitochondrial magnesium, while the deletion of the gene abolishes this 
high capacity influx.42 Evidence for the contribution of Mrs2 protein in 
mitochondrial Mg2+ uptake also come by the fact that knockdown of the gene 
results in functional defects of mitochondria, decrease of mitochondrial Mg2+  
and defect in RNA splicing. Moreover, expression of the bacterial CorA protein 
in yeast and targeted to the mitochondria, could partially compensate for these 
mutant effects by restoring wild-type levels of mitochondrial magnesium.41 
In human, the gene codifying for the active protein MRS2, is located on 
chromosome 6 and is composed of 11 exons, after translation the protein is 
transported to the inner mitochondrial membrane.45  
In human, it has also been demonstrated that the presence of MRS2 protein is 
necessary for human cell survival. In 2009 Piskacek et al. reported that knocking 
down MRS2 channel in human embryonic kidney (HEK-293) cells impairs the 
expression of the mitochondrial complex I of the respiratory chain, reduces the 
level of mitochondrial Mg2+, affects cell morphology and promotes apoptosis. It 
  Chapter 1- Magnesium 
 
13 
 
was shown that all these concomitant effects lead to the loss of cell viability 
within 2 weeks.46 It is unclear whether the decrease in mitochondrial Mg2+ 
depends on the absence of MRS2 or is due to the complex I depletion, which 
affects mitochondrial membrane potential Δψm and the consequently Mg2+ 
retention within the organelle.  
MRS2 expression has also been associated to drug resistance of gastric cancer 
cells. Chen et al. observed an up-regulation of this channel in doxorubicin 
resistant cells respect to the sensitive counterparts.47 Furthermore, they 
demonstrated that transfection with MRS2 in wild type cells confers Multi Drug 
Resistance (MDR) phenotype; conversely, knocking down the MRS2 partially 
reverse the acquired resistance.45 These results suggest a direct correlation 
between MDR phenotype and MRS2 expression. 
 
 
 
 
Figure 1 Model of the yeast (Saccharomyces cerevisiae) Mrs2 protein. The channel is  
assembled as a homopentamer resembling a funnel. The putative Mg2+-binding site is mapped 
in reds.40 
 
  Chapter 1- Magnesium 
 
14 
 
1.2.3 TRPM channels  
The transient receptor potential (TRP) ion channel family plays critical roles in 
mediating cellular responses to a wide range of physiological stimuli. This 
family of proteins is divided into six related sub family proteins, including the 
TRPM sub family members.48 
The melastatin-related TRP family (TRPM) is divided, in its turn, into four 
groups: TRPM1/3, TRPM2/8, TRPM4/5 and TRPM6/7.  
TRPM6 and TRPM7 were the first Mg2+ channels identified in mammalian cells 
by different approaches. Both proteins share the unique feature of an atypical 
kinase domain at their C-terminus for which they have been termed ‘chanzymes’ 
(channels plus enzymes). TRPM6 has also the faculty to phosphorylate residues 
of TRPM7 channel forming heterodimeric complexes as well as homodimeric 
complexes with itself. The two channels plus the heterodimeric complex are 
distinct ion channel exhibiting different divalent cation permeability, pH 
sensitivity and unique single channel conductance.2516,17 
 
TRMP6 is specifically located in the colon and in the distal convolute tubule of 
the nephron. This distribution strongly emphasizes the role of this channel in 
controlling whole body Mg2+ homeostasis via intestinal absorption and renal re-
sorption. Indeed, kidney is the principal organ involved in magnesium 
homeostasis. However, it is unresolved how Mg2+ accumulated in the apical 
domain of the tissue can be transported across the cytoplasm, delivered to the 
basolateral domain and be extruded into the blood plasma. One hypothesis is 
that baso-lateral Mg2+ extrusion occurs via Na+/Mg2+ exchanger. Impairment of 
TRPM6 expression has been associate to a genetic form of hypomagnesemia 
accompanied by hypocalcemia poorly restored by massive Mg2+ 
administration.17,49 
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TRPM7 is an ubiquitous channel founded in every mammalian tissue 
investigated to date. The TRPM7 channel was suggested to provide a major 
mechanism of Mg2+ entry into the cell, thus regulating both cellular and whole 
body Mg2+ homeostasis. 50 
The TRPM7 channel involvement in cellular Mg2+ homeostasis was 
demonstrated by genetic knockout experiments. This genetic manipulation led 
to an arrest of cell proliferation and reduced Mg2+ levels that could be restored 
exclusively by Mg2+ supplementation, suggesting that the major role of TRPM7 
is regulating Mg2+ intake. 50,51 Besides, TRPM7 activity is often regarded as a 
requirement for cell survival since genetic or pharmacological ablation led to an 
arrest in G0/G1 of cell cycle and genetic ablation of TRPM7 induce apoptosis of 
mast cells.50 All these data are consistent with the fact that proliferating cells 
require Mg2+. 
Regulation of  TRPM7 depends on cytosolic availability of Mg2+ and Mg2+-ATP2-. 
Activation of TRPM7 only occurs in the presence of physiological Mg2+ within 
the cell. However TRPM7 is not an exclusive Mg2+ channel being able to also 
transport other cations such as Ca2+ or Zn2+.17   
Despite the mounting evidence for TRPM7 as a regulator of Mg2+ homeostasis, 
recently has been published that TRPM7-deficient mouse showed altered 
embryonic development and disrupted thymopoiesis without affecting total 
intracellular Mg2+ concentration of T cells.5 
Concluding, TRPM7 is involved in a number of vital cellular processes in 
mammalian cells, and has gaining increasing attention for its potential role in 
cancers as a new diagnostic and prognostic marker, in addition to known 
biomarkers.52 
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1.2.4 Claudins 
Claudin-16 was the first Mg2+ transporter to be identified in mammalian cells. 
Mutation of this protein results in the Familial Hypomagnesaemia with 
Hypercalciuria and Nephrocalcinosis  (FHHNC) which is a is a genetic disease 
characterized by Ca2+ and Mg2+ wasting. This protein mediates paracellular Ca2+ 
and Mg2+ fluxes throughout the nephron. However, the modality by which 
these fluxes are generated is still controversial. CLND16 is a member of the 
claudin family, which are tight junction proteins with 4 trans-membrane spans 
coordinated by 2 extracellular loops, and with both C- and N-termini on the 
cytoplasm side.53 
Recently another claudin isoform has been shown to be involved in the 
reabsorption of   Mg2+ and Ca2+ : Claudin-19. This protein forms a heteromeric 
complex with claudin-16 at the level of the tight junction, with specific cation-
selectivity. Point mutation of both of these proteins affects the heteromeric 
interaction leading to development of FHHNC.5 
 
1.2.5 MagT1 
Mg2+ transporter 1 (MagT1) is an ubiquitously expressed Mg2+ channel. 
Although the identification of this channel dates back almost 10 years, the 
functional characteristics of MagT1 are still undetermined. The most available 
hypothesis is that MagT1 has similar function on TRPM7 in certain types of 
cells. In particular, it mediates rapid Mg2+ entry in T cells upon receptor 
activation.54 This hypothesis is also supported by the fact that overexpression of 
MagT1 can partially rescue cell growth and Mg2+ uptake in TRPM7-deficient 
cells.55  
 
  Chapter 1- Magnesium 
 
17 
 
1.2.6  SLC41 
Members of the Solute Carrier family 41 are found in all eukaryotic cells and 
show distant homology to the prokaryotes Mg2+ transporter MgtE. This family 
channel was first identified and characterized in 2003 and comprehend three 
family members: SLC41A1, SLC41A2 and SLC41A3.56   
SLC41A1 is the most extensively studied channel of his family thought to 
mediate Mg2+ transport across the plasma membrane, whereas SLC41A2 might 
be involved in the subcellular Mg2+ transport. Recently, has been found that the 
expression of SLC41A1 in HEK-293 cells leads to Mg2+ efflux, thus it has been 
proposed that this protein may function as Na+/Mg2+ exchanger with a 2:1 
stoichiometry.57 It seems that single nucleotide-polymorphisms (SNPs) of 
SLC41A1 have an impacts on neurodegenerative diseases, in particular with 
Parkinson’s disease.58 
 
1.2.7 CNNM 
Members of the Cyclin M proteins, also known as ACDP family, have been 
proposed to function as Mg2+ transporters. These proteins present more than 
50% of homology with the CorC transporter which is implicated in Mg2+ efflux 
in prokaryotes. CNNM1 is essentially restricted to the brain, CNNM2 
expression is high in kidney and CNNM4 is mostly expressed in intestine. On 
the contrary, CNNM3 is an ubiquitous channel and may play a role in the 
maintenance of cellular Mg2+ homeostasis. Furthermore this transporter seems 
to be involved in cancer. In particular, it has been found that CNNM3 activity is 
regulated by the oncogene PRL2 and that his interaction could be essential for 
Mg2+ influx that drives tumour progression. 59 
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Figure 2 Magnesium regulation by its transporters in vertebrate cells . The cartoon 
summarizes the combined action of Na+/Mg2+ exchanger, TRPM7, SLC41A1, Mag T1, and MRS2 
Mg2+ transporters as well as the main cellular functions regulated by changes in Mg2+ content 
within different compartments.56 
 
1.3 Regulation of Magnesium transport and homeostasis 
Over the last 20 years, the elucidation of the complex mechanism underlying 
Mg2+ transport across cellular membranes has been object of deep research. In 
particular, Mg2+ transporters are finely regulated by different metabolic stimuli 
such as hormonal and pharmacological factors including β-agonists, growth 
factors, and insulin. It has been suggested that a hormonally regulated 
magnesium uptake system controls intracellular magnesium concentration in 
cellular compartments. The magnesium concentration in these compartments 
would then serve to regulate the activity of magnesium-sensitive enzymes.60 
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Extrusion. Mg2+ extrusion, is mainly regulated by hormones such as 
catecholamine or glucagon. These hormones, known to increase cellular cAMP 
level by activating G-protein coupled receptors, are able to induce a rapid Mg2+ 
efflux by the activity of Na+/Mg2+ exchangers. Indeed, it has been shown that 
many different type of cells respond with a massive Mg2+ efflux returning to 
baseline levels within 8 minutes from the application of the stimulus. This 
temporally limited extrusion suggest that Mg2+ can be mobilized from a well-
defined cellular pool. The key role of cAMP mediated extrusion is further 
corroborated by the observation that pre-treatment of cells with hormones or 
agents that decrease cAMP levels, are able to prevent cellular Mg2+ 
mobilization.61,62 
However, cAMP independent Mg2+ extrusion mechanisms associated with α1-
adrenergic stimulation, have also been reported.63 In particular, administration 
of phenylephrine promotes Mg2+ extrusion from liver cells depending on the 
activation of capacitive Ca2+ entry. Hence, it would appear that an optimal level 
of cytosolic Ca2+ has to be reached in order to elicit Mg2+ extrusion. This 
mechanism evidences the crosstalk with Ca2+ signalling and Mg2+ homeostasis. 
Mg2+ extrusion can also occur in condition of low ATP levels within the cell. 
Indeed, cells exposure to agents or conditions decreasing ATP levels by several 
mechanisms, such as preventing the mitochondrial electron chain15 or acting as 
an ATP trap64, affects Mg2+  homeostasis. The impairment of Mg2+ can be 
attributed to the Mg2+-buffering role elicited from ATP within the cell. Indeed a 
decrease of ATP or its degradation in ADP or AMP results in an increase of free 
cytosolic Mg2+ which ultimately originates its extrusion from the cells. 
Accumulation. Although the regulation mechanism concerning Mg2+ extrusion 
are well known, information about structural details are still lacking. On the 
contrary, in the case of Mg2+ entry we have a lot of structural information about 
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channels and transporters but we need more  information about how they are 
regulated. 
The main pathway for Mg2+ accumulation in mammalian cells is the activation 
of protein kinase C (PKC). Evidence supporting role for PKC in mediating Mg2+ 
accumulation has been provided by several laboratories.65 Furthermore, 
inhibition of Mg2+ accumulation has been observed following treatment of cells 
with the PKC inhibitor staurosporine. 66 
However, other pathways are involved in the regulation of Mg2+ entry such as 
MAPKs and EGF signalling. 67  It has been shown that the inhibition of MAPKs 
signalling impedes Mg2+ entry and block cell cycle progression by affecting 
cyclin activity while EGF controls the TRPM6 channel expression and 
consequently Mg2+ reabsorption in kidney.68  
 
1.3.1 Perturbation of magnesium homeostasis 
Perturbation of Mg2+ homeostasis may result in impairment of electrochemical 
and electrolytic balance causing dysfunction of several tissues and organs.   
Serum magnesium levels above 1.1 mM are generally considered 
hypermagnesemia. The main symptoms of hypermagnesemia are nausea, 
vomiting, headaches or flushing. When Mg2+ arise above 3.0 mM it can lead to 
serious cardiac defects that are characterized by bradycardia or hypotension 
ultimately leading to coma, asystole or cardiac arrest. Fortunately, 
hypermagnesemia is rare, whereas hypomagnesemia is significantly more 
prevalent.  
Hypomagnesaemia, is defined as any serum concentration of magnesium under 
0.74 mM. Patients affected by hypomagnesaemia suffer from nonspecific 
symptoms such as depression, tiredness, muscle spasms and muscle weakness. 
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Diagnosis may take years, due to the absence of a routinely determination of 
serum Mg2+ level in patients5 
In general, the main causes of hypomagnesaemia are the following: chronic 
inadequate Mg2+ intake exacerbate by vomiting and diarrhoea; alcoholism 
caused by the block of Mg2+ uptake from ethanol.69,70 However there are also 
genetic causes of hypomagnesaemia often associated with deregulation of 
magnesium transporters. The most common genetic cause of isolated 
hypomagnesaemia are mutation in CLDN16 and TRPM6 channels. Mutation of 
CDLN16 causes Ca2+ and Mg2+ wasting, renal parenchymal calcification and 
renal failure. In this pathological condition Mg2+supplementation is not capable 
to restore normal serum Mg2+ levels or retarding disease progression.53 
Moreover, mutation in TRPM6 channel causes hypomagnesaemia with 
secondary hypocalcaemia resulting in severe neurological complications such 
as epilepsy and mental retardation.49 Similar defects are associated with 
mutation of CNNM2 channel, causative for hypomagnesaemia with Mg2+ serum 
levels range between 0.3 and 0.5 mM.71  
One of the most common side effects of chemotherapy and radiotherapy, 
especially in the treatment of tumours with cisplatin or when used in 
combination with anthracyclines or 5-fluorouracil is serum magnesium 
deficiency. The hypomagnesaemia induced by cisplatin is a consequence of the 
nephrotoxicity of this drug, causing tubular damage and consequently general 
electrolyte wasting.  
Syndromes of magnesium deficiency has also been observed in patients treated 
with the anti-epidermal growth factor (EGFR) IgG1 monoclonal antibody, 
cetuximab. It seems that cetuximab causes an inhibition of Mg2+ reabsorption in 
the renal distant convolute tubule, without affecting function or morphology of 
nephrons. TRPM6 channel is also involved as it is responsible for Mg2+ 
absorption in the intestine and kidney. Groenestage et al defined EGF as 
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magneisotropic hormones regulating renal Mg2+ reabsorption by controlling the 
activity of TRPM6.72 As a consequence, inhibition of the EGFR by anti-EGFR 
antibodies  such as cetuximab, lead to suppression of TRPM6 activity and renal 
Mg2+ wasting. 
 
1.4 Magnesium in Cell Biochemistry 
In 1927 Erdtman discovered the involvement of Mg2+ as activator of mammalian 
alkaline phosphatase 73 and since then a multitude of enzymes have been shown 
to be activated by this cation. Scientific literature reports a number of 300 
enzymatic reactions in which Mg2+ is involved, however this is an 
approximation largely underestimating the real figure. Currently, enzymatic 
databases list over 600 enzymes for which Mg2+ acts as a cofactor and other 200 
in which may act as direct activator.5 In particular, Mg2+ is implicated in those 
reactions utilizing ATP or catalyzing the transfer of phosphate. Indeed ATP 
hydrolysis to ADP is the most significative role of Mg2+ in energy metabolism 
and it is a matter of fact that all reactions involving ATP need the presence of 
Mg2+ ions as the functional ATP form is MgATP2-.74 Since ATP is essential for 
almost all of the biological processes that require energy, including oxidative 
phosphorylation, nucleic acid synthesis, protein synthesis and so on, the 
function of magnesium can be extended to all of those enzymatic reactions.75 
Mg2+ bounded to ATP is also needed in those reactions necessitating phosphate 
group transfer such as glukokinase, phohphofructokinase, 
phoshoglyceratekinase and pyruvatekinase.76 Consequently, Mg2+ availability is 
of major importance for glucose metabolism. Mg2+ can act as a cofactor in three 
ways: by stabilizing a reaction intermediate, ii) by stabilizing a product leaving 
group; iii) by binding two reactive substrates simultaneously and facilitating a 
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reaction trough a proximity effect. In addition Mg2+ can also bind directly to 
enzymes, thereby modifying enzyme structure or acquiring a catalytic role.77 
Mg2+ ion is an essential component of the RNA and DNA tertiary structures, as 
it binds the negatively charged O and N molecules within the polynucleotide 
chain. It has been observed that in Mg2+ deficient conditions, DNA is more 
accessible to free oxygen radicals and more prone to oxidative stress. On the 
other hand, higher Mg2+ concentration could deforming the double helix 
conformation. Hence, maintaining cellular Mg2+ concentration within the 
physiological range is essential for DNA stability.78 It has been found that DNA 
polymerases have two Mg2+ binding sites, hereby Mg2+ in necessary for the 
structure of DNA and RNA polymerases; moreover, the release of Mg2+ ions is 
necessary for the opening of the catalytic site for new nucleotides. 
Finally, the presence of Mg2+ is also important for the maintaining of genomic 
stability through ensuring the fidelity of DNA replication and repair 
processes.79  
 
 
1.4.1 Magnesium in Cell Signalling 
Mg2+ acts as a physiological Ca2+ antagonist within cells, and as a result, the 
Mg2+/Ca2+ ratio is of major importance for the activity of Ca2+-ATPases and other 
calcium transporting proteins. Small changes in the Mg2+ availability within the 
cell may therefore cause disturbed calcium signalling or toxicity related to it.80 
Moreover, a second messenger role for Mg2+ has been proposed when Mg2+ 
efflux was determined following insulin exposure. Recently, in a study on T-cell 
activation, MagT1 channels were shown to mediate Mg2+ influx upon T-cell 
receptor activation and EGF stimulation. In these cells, Mg2+ activates 
phospholipase C- (PLC), resulting in reduced phosphorylation of protein kinase 
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C (PKC) and inositol triphosphate (IP3) generation downstream, eventually 
leading to reduced Ca2+ influx. In contrast, other reports that PLC activation 
precedes Mg2+ influx. Prosecuting studies demonstrated that MagT1-deficient 
cells have severely reduced basal intracellular Mg2+ concentrations, suggesting 
that the effects seen on PLC are dependent on general intracellular Mg2+ 
availability.81 
 
1.4.2 Magnesium and Cell Proliferation 
Since 1980s several investigators described the essential role of Mg2+ in the 
proliferation of yeast and mammalian cells. Mg2+ might reasonably be involved 
in every single step of the mitogenic signalling cascade: from receptor-mediated 
mitotic signals and transphosphorylation reactions to gene transcription and 
protein synthesis.82 
Coherently with the promoting role of Mg2+ on protein and DNA synthesis, 
proliferating cells contain more Mg2+ than resting ones.83 
Cell proliferation, as well as cell cycle and differentiation, require appropriate 
Mg2+ level to occur, hence they could be really compromised in non-
physiological conditions influencing Mg2+ concentration and homeostasis. For 
example, Mg2+ deprivation induces inhibition of DNA and protein synthesis, 
thus leading to growth arrest. This effect is mainly due to the decreased amount 
of Mg2+ bounded to ATP. However, different cellular types vary in their 
dependence on the extracellular Mg2+ availability. In general, diploid cells are 
highly sensitive to changes in magnesium availability: endothelial cells and 
fibroblasts decreased their growth rate to a considerable extent when the cells 
were maintained in 0.1 mM extracellular Mg2+. Intriguingly, immortalized cells, 
showed a 50% growth inhibition only upon exposure to 0.05 mM Mg2+.84 
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Tumour cells proved to be the most resistant ones, showing an unaltered 
growth rate at 0.05 mM extracellular Mg2+.85 
Furthermore, it has been shown that Mg2+ deprivation induces an arrest of cell 
cycle progression in G0/G1 phase and a decreased percentage of cells in the S 
phase; however cell cycle arrest is reversible by adding Mg2+ in the culture 
medium. On the contrary increasing the amount of extracellular Mg2+ induces 
activation of cell cycle. It has been reported that MAP kinases protein trigger 
this reactivation, leading to up-regulation of cyclins D and E and decreased 
expression of p21 and p27.86 The modulation of cell cycle regulatory proteins 
such as p21 and p27, cyclins and CDKs is a common feature of the Mg2+-
dependent control of cell proliferation.87 This suggests that Mg2+ availability 
affects cell cycle by influencing the transcription of the related gene, as shown 
in figure 3. 
To discern the complex but coordinated growth response that drives cell 
proliferation Harry Rubin postulated the theory of “Membrane Magnesium 
Mitosis”, suggesting a role of second messenger for cytoplasmic free Mg2+. The 
basic concept of this theory is that membrane perturbations induced by growth 
factors causes a decrease of Mg2+ binding affinity with consequent increase in 
intracellular Mg2+ levels. The release of Mg2+ triggers in turns protein and DNA 
synthesis increasing number of MgATP2- dependent reactions, ultimately 
leading to cell division. In this view, Mg2+ acts as a direct regulator of cell 
proliferation.88 
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Figure 3 Pathway of cell proliferation and its regulation by Mg2+. Mg availability may affect 
all steps leading to cell proliferation, from signal transduction to mitosis. At the molecular level, 
low Mg up-regulates p27 and p21 inhibitory proteins, leading to cell cycle arrest through 
inhibition of cyclin/CDK complexes and consequent inhibition of the Rb (retinoblastoma)-
regulated restriction point. (Adapted from Wolf et al.2008)87 
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1.4.3 Magnesium and Apoptosis 
Increasing evidences indicate a potential role for Mg2+ cation in the apoptotic 
process; however, the available literature is limited and often ambiguous.  
Both intrinsic and extrinsic pathways of apoptosis have been shown to be 
accompanied by variations in cytosolic magnesium, most of all in the early 
stages of the process.87 We recently reported a decrease of both free and total 
magnesium during mitochondria-mediated apoptosis in colon cancer cells 
concomitant with increased level of Reactive Oxygen Species (ROS).89,90 In this 
conditions, the analysis of the early events characterizing the trigger of 
apoptosis showed that, while the decrease in the total content were maintained, 
free Mg2+ levels correlated with ΔΨm variations.91 
These data are in agreement with that described by Li et al. reporting that a 
decline in free cytosolic Mg2+ was observed during peroxynitrite-induced 
apoptosis in rat aortic smooth muscle cells.92  Furthermore, it has been shown 
that Mg2+ deprivation in rat hepatocytes induces apoptosis by an increased 
susceptibility to oxidative stress provoked by a decrease in glutathione 
concentration and an increase in lipid peroxidation.93 On the other hand, several 
studies have indicated a promoting role for Mg2+ in apoptosis; it was 
hypothesized that apoptosis is promoted by an influx of Mg2+ which stimulates 
the activity of nuclear endonucleases.94 Moreover, Mg ions seems to potentiate 
the release of proapototic factors from the mitochondria.95 
Given the pivotal role of mitochondria in the apoptotic process, the presence of 
a selective Mg2+ channel in the inner mitochondrial membrane, MRS2, which 
activity is regulated by ΔΨm status, strongly suffrages the hypothesis of Mg2+ 
involvement in the apoptotic onset. 
Other evidences point to an involvement of Mg2+ in the prevention of apoptosis. 
It has been showed that the administration of magnesium sulphate inhibits 
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caspase-3 activation and exert antiapoptotic effect after hypoxia-ischemic brain 
injury in rats and reduced neuronal apoptosis. 96,97 Accordingly, it has also been 
demonstrated that magnesium sulphate administration attenuates the marked 
alteration of the ratio of Bax and Bcl-2 protein during hypoxia. 98  This data 
suggests that magnesium sulphate treatment before and during hypoxia may 
decrease programmed cell death by keeping constant Bax / Bcl-2 ratio.  
 
1.4.4 Magnesium and Cancer 
Tumour tissues are characterized by high proliferation rate, dedifferentiation 
and invasiveness.99 All these process need energy to occur and consequently 
Mg2+ availability. 
In particular, Mg2+ involvement in carcinogenesis is mainly due to Mg2+ 
deficiency conditions responsible for increasing of inflammation and free 
radicals levels leading to oxidative DNA modifications and mutagenesis. 
Moreover, Mg2+ deficiency can be also responsible of defects in DNA repair 
mechanisms which dysfunction compromises genomic stability leading to 
genomic alterations.74 On the other hand, magnesium could exert also 
protective effect in the early stage of carcinogenesis as magnesium hydroxide 
supplementation reduces the incidence of colon cancer in animal models.100 
Once the process of carcinogenesis is concluded, all the efforts are directed to 
inhibit tumour growth and angiogenesis. Many findings are consistent to a 
protective role of low magnesium availability. Unfortunately, the beneficial 
effects of low magnesium in tumour cell proliferation and neo-angiogenesis are 
counterbalanced by the higher possibility to develop metastasis.101 
Referring to normal cells, they show a correlation of the growth rate with 
magnesium availability; in contrast, tumour cells are completely independent 
from this parameter and ceased to proliferate only when extracellular 
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magnesium is very low. Unbalanced magnesium homeostasis is frequently 
observed in tumour cells that accumulate Mg2+ at the expenses of plasma or 
normal tissues. Tumour cells show great affinity for Mg2+ even when cultured in 
low magnesium concentration. The propensity of neoplastic cells to accumulate 
Mg2+ may be due to the wrong function of cellular extrusion mechanisms or to 
the overexpression of influx channels.102 The most accredited influx channel 
involved in cancer is TRPM7.52 
TRPM7 seems to be required for proliferation of several types of tumour cells, 
including leukaemia, retinoblastoma, and carcinoma cells of pancreatic, breast, 
gastric and head and neck origins. Furthermore increased TRPM7 expression 
was found in human breast and pancreatic adenocarcinoma tissues, where it 
correlated with clinic pathological parameters, such as tumour grade and 
patient survival.103 
Interestingly, it has been suggested that hypomagnesemia could be considered 
a predictive factor of efficacy and outcome in colorectal cancer patients treated 
with cetuximab+irinotecan. In fact, those patients with an early decrease of 
serum Mg2+ ion presented better median time to progression and longer overall 
survival (OS) to patients with <20% reduction of serum magnesium.104 In the 
light of requirement of magnesium in tumour growth, these findings suggest 
that magnesium deficiency could be used parameter for the efficacy of the 
treatment avoiding a costly a potentially toxic administration in non-responder 
patients.  
 
1.4.5 Magnesium and Drug Resistance 
Multi drug resistance is a phenomenon characterized by the ability of drug 
resistant tumours to exhibit simultaneous resistance to a number of structurally 
and functionally unrelated chemotherapeutic agents.105 MDR is the principal 
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mechanism by which many cancers develop resistance to chemotherapy drugs 
and the major factor in the failure of many forms of chemotherapy. Resistance 
to therapy has been correlated to the presence of at least two molecular 
“pumps” in tumour-cell membranes that actively expel chemotherapy drugs 
from the intracellular compartment. This allows tumour cells to avoid the toxic 
effects of the drug on molecular processes within the nucleus or the 
cytoplasm.106  
While the original role for these proteins was to protect animals from 
xenobiotics, MDR pumps might also transport "normal" substances, such as 
steroids and some fats, out of cells. The two pumps commonly found to confer 
chemoresistance in cancer are P-glycoprotein (P-gp) and the so-called 
multidrug resistance–associated protein (MRP). High expression of P-gp has 
been observed in LoVo colon cancer cells resistant to doxorubicin. Furthermore, 
P-gp was found in the plasma membrane, in the intracellular membranes, and 
in the nuclear envelope of LoVo resistant cells.107 However, it has becoming 
increasingly evident that there are probably other multidrug resistance–
inducing macromolecules in cancer cells that have not yet been characterized.108  
Most cytotoxic chemotherapeutics eliminate tumour cells by activating the 
intrinsic apoptotic pathway.109 In this view, success of many therapeutic agent 
depends on the ability to induce apoptosis as one of the proposed mechanism 
by which cancer cells develop resistance to drugs is the defect of apoptosis 
signalling.110 Tumour cells can acquire resistance to apoptosis by the expression 
of anti-apoptotic protein such as Bcl-2 or by down-regulation or mutation of 
pro-apoptotic protein such as Bax.  
Wide ranges of mechanisms have been suggested in overcoming drug induced 
apoptosis. In this regard Mg2+ may play a role. 
In particular, it has been proposed a role for the mitochondrial Mg2+ channel 
MRS2 in circumventing drug induced apoptosis in gastric cancer cells. 45 
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It has been shown that MDR gastric cancer cells present an up-regulation of the 
gene codifying for MRS2 protein compared to its parental cells.47 Furthermore, 
MRS2 transfection was shown to confer an MDR phenotype to gastric cancer 
cells; vice versa, MRS2 knock down partially reversed the MDR phenotype in 
cells with acquired resistance. In view of these findings, the most accepted 
hypothesis is that overexpression might counteract drug-induced apoptosis by 
increasing magnesium influx into mitochondria.111  
Notably, increased magnesium content has been reported in tumour 
mitochondria or cells. It has also been shown, that a cis-platin resistant human 
ovarian carcinoma cell line (C13*) presents a significantly higher Mg2+ content 
than the sensitive parental cells. Since mitochondria, along with nuclei and 
microsomes, represent preferred compartments of Mg2+ accumulation, 
mitochondria alterations acquired by C13* cells during resistance selection may 
at least partly account for their elevated Mg2+ concentration compared to 
sensitive cells.112 An alternative, but not mutually exclusive, hypothesis is that 
magnesium could potentiate mitochondrial energetic function and 
consequently the activity of efflux pumps, which are highly dependent on 
ATP.103 
 
 
1.5 Intracellular magnesium determination 
Although magnesium is essential for a number of biological processes crucial 
for cell life, its distribution and intracellular compartmentalization have not 
been elucidated yet, mainly because of the lack of suitable analytical methods. 
Furthermore, Mg2+ seems to be well buffered within the cytoplasm implying 
that Mg2+ fluctuations could only be traced by techniques able to sense minor 
changes.,113 
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To date, the most common approach to assess total cellular magnesium in the 
cell or tissue is by Flame Atomic Absorption Spectroscopy (F-AAS) on acidic 
extracts, a technique that requires large samples (at least millions of cells or 
several milligrams of tissue). Other more sensitive techniques require smaller 
sample sizes, such as Inductively Coupled Plasma Mass Spectroscopy (ICP-MS) 
and Graphite Furnace AAS (GF-AAS). These techniques indubitably offer 
improved detection limits, however require instrumentations not easily 
available in any laboratory, complex analytical procedures and specific 
technical skills and competencies.114  
Another method to assess the intracellular concentration of Mg2+ is by 
phosphorus magnetic resonance spectroscopy31P NMR. This technique is based 
on the fact that most of magnesium in the cytosolic matrix is bound to ATP. 
Therefore variation in the acquired chemical shift associated to the 
phosphorylated molecule present in the cytoplasm including Inorganic 
Phosphate (Pi), Phosphocreatine (PCr) and ATP depends on the Mg2+ 
concentration. While non-invasive, 31P NMR measures Mg2+ indirectly 
averaging over a large collection of cells.115 
 
1.5.1 Fluorescent chemosensors 
Although the importance of Mg2+ is widely acknowledged, all the efforts in 
developing fluorescent probes have been made to study and monitor Ca2+ 
concentration in vivo, as fast-acting principal second messenger; therefore, Mg2+ 
has become the “forgotten” cation in human health. Hence, the development of 
Mg2+ selective probes derived from the cross reactivity of Ca2+ probes. 113 
Therefore, the design of highly selective Mg2+ fluorescence probes is an 
intriguing challenge as is confirmed by the last development in this field.116  
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The first developed fluorescent Mg2+ indicators, APTRA (o-amminophenol-
N,N,O-triacetic acid) family and it derivatives, are structural analogues of Mg2+ 
chelator EDTA (ethylendiaminetetraacetic acid); these molecules have been 
used as 19F NMR indicators. Subsequently, the APTRA structure has been 
modified around the furan ring resulting in the FURAPTRA (mag-fura-2) which 
is still used in many laboratories.117,118 Since then, many others probes has been 
synthetized to be selective for Mg2+ ion, however they were simply analogues of 
the corresponding Ca2+ indicators. 
The currently most commonly applied approach uses synthetic dyes that alter 
their fluorescent properties upon binding of Mg2+. However, many of the 
available dyes show limited specificity for Mg2+ and often bind Ca2+ with low 
micromolar affinity, which has been shown to interfere in an intracellular 
setting. The AMg1 fuorescent dyes developed by Kim et al., whose high two 
photon cross-section makes them suitable for two photon confocal microscopy, 
partially discriminate between membrane and cytosolic Mg2+.119 
A notable exception is the family of fluorescent molecules, diaza-18-crown-6 8-
hydroxyquinolines derivatives (DCHQ) that show a remarkable affinity and 
specificity for magnesium reporting a Kd value for Mg2+ in the order of the 
micromolar range. Indeed, commercially available Mg2+-specific luminescent 
probes are all characterized by Kd(Mg2+) values in the millimolar range: 
therefore, they are suitable to detect mainly free cytosolic magnesium ions (only 
5% of the total) without providing any information about total fraction. This 
unique characteristic of DCHQ molecules, permit to detect total intracellular 
magnesium giving a concentration value fully comparable to that obtained with 
AAS. The most promising derivative of this family is the DCHQ5 chemosensor 
which presents many advantages including the high intracellular retention or 
the possibility to avoid the UV excitation  which could be potentially cytotoxic, 
as it could be excited both in the UV and Visible wavelength regions. 120 
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Among fluorescent chemosensors, particular interest has been recently raised 
by KMG-104 and related dyes developed by Kuzuki and coworkers, whose 
affinity for Mg2+ is higher than for Ca2+, rendering these dyes completely 
insensitive to physiological changes in cytosolic Ca2+ concentration. Recently a 
variant of this dye, KMG-103 was reported to show preferred accumulation in 
mitochondria.121  
Last development in the field of fluorescence chemosensor is referred to the 
genetically encoded metal sensors based on the Förster Resonance Energy 
Transfer (FRET). These sensors do not require cell-invasive procedures, their 
concentration can be tightly controlled and they can be targeted to different 
locations in the cell. In particular, the first developed genetically encoded 
fluorescent sensor (MagFRET-1) for Mg2+ shows a 50% increase in emission ratio 
upon Mg2+ binding. A general advantage of genetically encoded sensors is that 
their subcellular localization can be easily controlled.  
Although MagFRET-1 is responsive to changes in Mg2+ concentration in 
permeabilized cells, for some unknown reason MagFRET-1 is less responsive in 
intact cells. Moreover, MagFRET-1 responds to changes in Mg2+ concentration in 
the order of seconds both in vitro and in cells, but miss sensitivity for changing 
in overall Mg2+ levels over longer periods of time. These changes may be more 
reliably monitored using lifetime imaging (FLIM), which might also be the 
preferred method to allow quantification of intracellular Mg2+ concentrations.122 
Even though this technique allows to study Mg2+ variations in the intracellular 
compartment of a single cell it does not give an absolute quantification of the 
element. 
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1.5.2 X-Ray microscopy  
Recently, one of the main focus of life science in elemental quantification is 
direct to single cell analysis. Indeed, the possibility to have a map of whole 
single cells could give important information about morphology of the cell, 
amount of element constituting the cell and more important elemental 
distribution and compartmentalization in the cell organelles. 123 
Knowledge of the distribution of the chemical elements in organelles may 
reveal their function in a variety of cellular processes. Element imaging can be 
achieved by use of several micro-analytical techniques, for example 
histochemical techniques, radioisotope imaging, magnetic resonance imaging, 
mass spectrometry imaging, and microprobe X-ray fluorescence imaging.  
Apart from the aforesaid MagFRET-1, magnesium content in different 
subcellular compartments can be evaluated by electron probe microanalysis 
(EMPA) which operates by using an electron microscope and bombarding a 
micro-volume of a sample with a focused electron beam (typical energy = 5-30 
keV) and collecting the X-ray photons thereby emitted by the various elemental 
species. Because the wavelengths of these X-rays are characteristic of the 
emitting species, the sample composition can be easily identified by recording 
WDS spectra (Wavelength Dispersive Spectroscopy).124 
Another technique proved its usefulness for element imaging and speciation 
analysis in eukaryotic cells is the X-ray microspectrometry methods based on 
synchrotron radiation 125 
Micro and nano-SXRF (synchrotron X-ray fluorescence) can be used for imaging 
element distribution at high spatial resolution (<100 nm), and micro-XAS (X-ray 
absorption spectroscopy) has quite unique capability for direct determination of 
element speciation in cellular compartments, because it can be used to probe the 
local structure of the absorbing element with high chemical sensitivity. The 
increased spatial resolution of these methods achieved in recent years now 
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enables imaging of element distribution within the main cellular organelles, 
nucleus, Golgi apparatus, endoplasmic reticulum, vacuoles, lysosomes, 
mitochondria, and chloroplasts. However, identification by optical microscopy 
before X-ray imaging is usually limited to the larger organelles, i.e. the nucleus, 
the cytoplasm, and the vacuole. By using the principles of this technique a new 
developed method allows to address Magnesium in subcellular compartments. 
This new method combines X-Ray fluorescence microscopy and Scanning 
transmission X-Ray Microscopy to Atomic Force Microscopy and has been 
made thanks to the availability of synchrotron radiation sources and 
improvements in X-ray optics.126 
 
 
   
 
 
 
2 APOPTOSIS 
2.1 Introduction 
The term “apoptosis” is derived from the Greek words “aπο“ and “πτωsιζ“ 
meaning “dropping off” and refers to the falling of leaves from trees in autumn.  
It is used, in contrast to necrosis, to describe the situation in which a cell 
actively pursues a course toward death upon receiving certain stimuli.127,128 
Kerr et al firstly described apoptosis as an active and highly organized form of 
cell death characterized by biochemical events of removing stressed or 
damaged cells within multicellular organisms that result in specific 
morphological changes.129,130  
This form of cell death is characterized by membrane blebbing, cell shrinkage, 
nuclear fragmentation, chromatin condensation and chromosomal DNA 
fragmentation. This process, which plays a crucial role in embryonic 
development, is necessary to maintain tissue homeostasis as its deregulation 
results in a variety of diseases including tumorigenesis. 131  
Moreover, evasion of apoptosis is one of the hallmarks of cancer and confers 
drug resistance to cancer cells. Apoptotic mechanisms are divided into two 
main pathways.132 The ‘‘extrinsic pathway’’ is activated by extracellular death 
ligands and cognate death receptors (e.g., tumor necrosis factor-a [TNF-a]); and 
the ‘‘intrinsic pathway,’’ which responds to intracellular stress signaling (e.g., 
macromolecular damage), is mediated by mitochondria.  
During the intrinsic pathway of apoptosis, the permeabilization of the 
mitochondrial membrane and the consequently release of pro-apoptotic factors 
ultimately lead to the activation of a special class of cleaving enzyme called 
caspase, representing a point of no return in apoptosis. Caspases are a family of 
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cysteine proteases with roles in apoptosis, inflammation, and development. In 
healthy cells, caspases reside in the cytosol as inactive pro-enzymes and direct 
association with molecules of the inhibitor of apoptosis protein (IAP) family 
maintains their inactive state. 
This class of enzyme, are involved both in the intrinsic and in the extrinsic 
pathway of apoptosis. Caspase-8 and caspase-9 are the initiator caspases of the 
extrinsic and intrinsic apoptosis pathways, respectively, that in turn mediate 
activation of the executioner caspase-3 to evoke many of the defining 
biochemical and biophysical changes that occur during apoptosis.  
 
2.1.1 Intrinsic Pathway of Apoptosis 
The intrinsic apoptotic pathway can be activated by range of stress stimuli, 
including UV radiation, ROS, DNA-damaging agents or activation of oncogenic 
factors.132 The key event of this process, which is also known as mitochondria 
mediated apoptosis, is the mitochondria outer membrane permeabilization 
(MOMP).  
When in 1990, the anti-apoptotic function of the oncogene B cell lymphoma 2 
(Bcl-2) were found to be implicated in the commitment of this membrane 
permeabilization, regulation of apoptosis at mitochondria level emerged as a 
great opportunity for intervention in pathological conditions such as cancer. 
In particular, Bcl-2 proteins control MOMP by acting as either inhibitors or 
activator of the apoptotic process. 133 
At molecular level, two pro-death members of the Bcl-2 family, Bax and Bak 
induce the MOMP. These proteins oligomerize and are inserted into the outer 
membrane of mitochondria, which disrupt organelle membrane potential and 
also induce a rapid release of cytochrome c, Smac/DIABLO, and HTRA2/O from 
the intermembrane space into the cytosol.  
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Through MOMP, the pro-apoptotic inter membrane space proteins relocalize to 
the cytosol to initiate caspase activation, and this process generates the 
mitochondrial signal required for the intrinsic pathway to proceed. 
In particular, cytochrome c forms a complex with APAF-1 and pro-caspase 9 
named “apoptosome”, whereas Smac/DIABLO binds to inhibitors of apoptosis 
proteins (IAPs). Consecutively, the executioner caspase-3 is recruited to the 
apoptosome, where it is activated by the resident caspase-9. Caspase-3 then 
cleaves key substrates in the cell to produce many of the cellular and 
biochemical events of apoptosis.134  
 
2.1.2 Extrinsic Pathway of Apoptosis 
The extrinsic pathway of apoptosis is mediated by ligands activating death 
receptors (DR). Death receptors belong to the tumour necrosis factor (TNF) 
receptor superfamily, and include functional receptors and decoy receptors. 
The receptor superfamily includes TNF-R1, Fas/APO1, DR3, TNF-related 
apoptosis-inducing ligand receptors-1 (TRAIL-R1, DR4), -2(TRAIL-R2, DR5), 
and DR6. Others TNF receptors regulate several biological functions including 
cell metabolism, proliferation and cytokine production. These death receptors 
have an intracellular death domain that recruits adapter proteins such as TNF 
receptor-associated death domain (TRADD) and Fas-associated death domain 
(FADD), as well as cysteine proteases like caspase 8. Ligation and 
oligomerization of Fas, TNF receptor 1, or the TRAIL receptor triggers 
formation of a receptor-associated death-inducing complex (DISC) for 
recruitment and activation of caspase-8 and 10. High levels of active caspase-8 
generated by large amounts of procaspase-8 processing at the DISC lead to the 
activation of executioner caspases, including caspase-3, and the induction of 
apoptosis. Activation of caspase-8 can also result in the cleavage of the BH3-
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only protein BID to generate the activated BID fragment tBID, which serves to 
transmit the death signal from the extrinsic to the intrinsic signaling 
pathway.(see Fig. 4). 
 
 
Figure 4 Intrinsic and Extrinsic pathway of apoptosis132. In the intrinsic pathway, 
mitochondrial outer membrane permeabilization (MOMP) results in the release of cytochrome c 
and other apoptogenic factors from mitochondria into the cytosol and the ensuing formation of 
the apoptosome, which triggers activation of the apoptosis-inducing caspase cascade via 
activation of caspase-9. In the extrinsic pathway, binding of death receptors such as FAS or 
TRAIL receptors by their cognate ligands triggers the recruitment of death domain (DD)-
containing adaptor proteins (represented by FADD) and procaspases with a death effector 
domain (DED), specifically procaspase-8 and procaspase-10. The resulting complex is known as 
the death inducing signaling complex (DISC). High levels of active caspase-8 generated by large 
amounts of procaspase-8 processing at the DISC lead to the activation of executioner caspases, 
and the induction of apoptosis.  
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2.2 Apotosis in cancer therapy 
Cancer is the result of a succession of genetic changes during which a normal 
cell is transformed into a malignant one; the hampering of cell death is one of 
the essential changes that cause this malignant alteration. Hence, reduced 
apoptosis or its resistance is an important link of the triggering of 
carcinogenesis.  
Defects in the apoptotic process is also a very common cause of resistance to 
anticancer drugs. Therefore, apoptosis is a fundamental parameter to be 
considered in the treatment of cancer and represents a popular target of many 
treatment strategies.  
There are many ways a malignant cell can acquire reduction in apoptosis or 
apoptosis resistance such as disrupted balance of pro-apoptotic and anti-
apoptotic proteins, reduced caspases function and impaired death receptor 
signalling. Many proteins have been reported to exert pro- or antiapoptotic 
activity in the cell. Imbalance or dysregulation of these proteins have been 
found to contribute to carcinogenesis by reducing apoptosis in cancer cells. 127 
Disruption in the balance of anti-apoptotic and pro-apoptotic members of the 
Bcl-2 family, results in deregulation of apoptosis. Moreover, it has been 
suggested  that the loss of caspases-3 expression and function could contribute 
to breast cancer cell survival. 135 
Among intracellular organelles, mitochondria play a pivotal role in apoptosis, 
as a consequence damage to these organelles or to mitochondrial DNA may 
promote tumors formation by the inhibition of apoptosis of pre-cancerous cells.  
Indeed it has been found that cells lacking of mitochondrial genome, defined as 
rho0 cells, are less sensitive toward different apoptosis-inducers, including 
staurosporine, doxorubicin, daunomycin and quercetin, when compared to 
parental cells. 136Furthermore, rho0 cells exhibit over-expression of multidrug 
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resistance 1 (MDR1) gene and its product P-glycoprotein (P-gp). Combined 
with standard anticancer strategies, application of compounds directly affecting 
mitochondrial functions is a promising approach for eradication of 
chemotherapy-resistant cancer cells. 
 
 
 
 
 
FIGURE 5 Mechanisms of evasion from apoptosis 
 
 
 
   
 
 
 
3 AIMS 
 
Understanding apoptosis mechanisms may give insights into the pathogenesis 
of many disease and may leave indications on how the disease can be treated.127 
In the case of tumour treatment, most of the cytotoxic chemotherapeutic agent 
eliminates tumour cell by activating the mitochondrial apoptotic pathway.137 
However, prior to this terminal stage of apoptosis cells fight to resist 
pharmacological insults. 
In certain conditions, cancer cells develop the possibility to avoid apoptosis 
induction and become resistant to the administrated drug and to other 
unrelated drugs. This phenomenon is termed multi drug resistance (MDR). The 
acquired or intrinsic MDR is the major obstacle in achieving the effective 
chemotherapy in malignant tumours. However, the mechanisms of MDR 
remains obscure.45 
Because of the pivotal role of mitochondria in apoptosis, they are also involved 
in tumour formation by the inhibition of apoptosis of pre-cancerous cells.  
Indeed, mutations in genes involved in the regulation of the mitochondrial 
pathway are very common in cancer cells and mitochondrial ion channels are 
emerging as promising targets for cancer treatment.138 Among mitochondrial 
ion channels MRS2 is the only known Magnesium transporter in mitochondria. 
Interestingly, the expression of MRS2 channel has been associated with 
resistance to drug-induced apoptosis in cancer cells.139  
It is worth remembering that mitochondria are the major Mg2+ store in the cell.15 
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Considering the prominent role of Mg2+ in cell proliferation it is evident that 
perturbations in the intracellular Mg2+ concentration could have serious 
implications for the proper functioning of cells.  
Thus, the involvement of Mg2+ cation changes could result in altered Mg2+ 
compartmentalization and mobilization and might eventually modify the 
progression of apoptosis. 
In the first part of the project, carried out in collaboration with Dr. Martin 
Kolisek and Dr. Gerhard Sponder, at the Free University of Berlin, we 
investigated the involvement of magnesium and its mitochondria transporter 
MRS2 in the apoptotic process, eventually leading to multi drug resistance 
phenotype.  
Aimed to reach a regulated expression of MRS2 we generated an appropriate 
transgenic cellular system by using human embryonic kidney cells (HEK-293). 
After checking the induced protein expression we performed Mg2+ uptake 
experiments in isolated mitochondria to confirm the influx activity of the 
channel. Furthermore, aimed to verify if modulation of this channel could have 
an impact also on the total amount of cellular Mg2+, we examined total 
intracellular Mg2+ content in cells overexpressing MRS2. 
However, the main goal of this research was to investigate whether MRS2 could 
influence the sensitivity to apoptotic treatment. Cells transiently overexpressing 
MRS2 were exposed to two commonly used molecules in chemotherapy able to 
induce apoptosis; the efficacy of the drugs and the eventually anti apoptotic 
effect of Mg2+ channel were evaluated by cell cycle analysis, morphological 
analysis and caspase activity assay. 
 
The second part of this research was aimed to verify whether magnesium 
intracellular content and compartmentalization could be used as a signature to 
distinguish MDR tumour cells from their drug-sensitive counterparts.  
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To accomplish this objective we have chosen a tumour cell line, more 
appropriate for studies on the MDR phenotype. 
Measurements on LoVo human colon cancer cells sensitive (LoVo-S) and 
resistant (LoVo-R) to doxorubicin were performed to investigate cellular Mg2+ 
concentration changes in MDR tumour cells to better understand the 
involvement of Mg2+  in multi-drug resistance.  
We exploited a  standard-less approach providing a complete characterization 
of whole single-cells by combining X-Ray Fluorescence Microscopy (XRFM), 
Atomic Force Microscopy (AFM) and Scanning Transmission X-ray Microscopy 
(STXM). This method allows the quantification of the intracellular spatial 
distribution and total concentration of magnesium in whole dehydrated cells. 
Subsequently, aimed to compare single cells analysis with large cell population 
we quantified the total amount of intracellular Mg2+ in a large populations of 
cells by using DCHQ5 probe and traditional fluorimetric technique.  
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4 MATERIALS AND METHODS 
 
 
Part I 
 
4.1 Cell Culture and reagents 
Clone 2 cells derived from Human Embryonic Kidney cells (HEK-293) were 
grown in Dulbecco’s modified Eagle’s medium (DMEM) containing 4.5 g/l 
glucose, 3.7 g/l NaHCO3 and 110 mg/l pyruvate, supplemented with 10% fetal 
bovine serum (FBS, Biochrom) L-glutamin 2mM, penicillin 100 U/mL and 
streptomycin 100 µg/mL. Cultures were kept at 37°C in 5% CO2 atmosphere.  
Recombinant human MRS2 was purchased Synthesisgene. Doxorubicin 
hydrochloride was purchased from Sigma Aldrich and dissolved in sterile 
ultrapure water and stored at -20°C.  
Staurosporine was purchased from Sigma Aldrich as film, dissolved in 
Methanol and stored at 4°C. The concentration of the solutions was assessed by 
spectrophotometer  assays. 
 
4.2 T-RExTM System 
HEK-293 cells were stably transfected with pcDNA6TM/TR (Invitrogen) plasmid 
and selected with blasticidin (Labogen).140 Before transfection, the sensitivity of 
HEK-293 cells to blasticidin was evaluated. 
The pcDNA6TM/TR vector expresses high levels of the Tet repressor gene which 
enables the host cell line to keep the protein expression levels very low before 
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the tetracycline induction; the plasmid includes as well the blasticidin resistance 
gene under the control of the SV40 promoter which allows the selection of cells 
stably transfected with the plasmid. The pcDNA6TM/TR was transfected into 
HEK-293 cells using Polyethylenimine (PEI) as transfection reagent and the 
cells, which had stably integrated the vector in their genome and which 
therefore express the Tet repressor, were selected using blasticidin 15 µg/mL.  
The generated cell line stable transfected with pcDNA6TM/TR vector were 
named “Clone 2”. 
 
4.3 Cell growth curves 
 HEK-293 cells and their stable transfected counterpart Clone 2, were 
trypsinized, centrifuged and the pellet was resupsended in 2.5 mL of medium. 
The cells were counted by using Hemocytometer every 24 hours.  
The population-doubling time has been determined by identifying a cell 
number along the exponential phase of the curve, tracing the curve until that 
number has doubled, and calculating it by the following equations: 
 
 
Eq.1 
 
 
 
where Nt cell number at certain  time point t 
  N0 cell number at time point 0 
  T is the exponential time phase 
  n number of generation 
 
𝑛 =
𝑙𝑜𝑔𝑁𝑡 − 𝑙𝑜𝑔𝑁0
𝑙𝑜𝑔2
 
𝐷𝑇 =
𝑇
𝑛
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4.4 Cell transfection 
The blasticidin selected cells, “Clone 2”, has been used as Tet repressor 
expressing cell line for the following experiments requiring a well-regulated 
over-expression of MRS2. Clone 2 cells were grown in the above-mentioned 
DMEM supplemented with 15 µg/mL blasticidin in order to keep the Tet 
repressor selection. 
Transiently over-expression of MRS2 was performed in Clone 2 by transfection 
with the pcDNA5TM/TO-MRS2 vector under the control of cytomegalovirus 
(CMV) promoter and tetracycline operator sites.141 Protein expression was 
induced by addition of tetracycline (Sigma, Sigma-Aldrich, St Louis, MO, USA) 
to a final concentration of 1 μg/ml.  
 
4.4.1 Plasmid Constructs 
The MRS2 gene was synthesized and cloned via a 5’ KpnI and a 3’ XhoI 
restriction site into pcDNA5TM/TO. For transfections, all the recombinant 
plasmids were prepared using the NucleoSpin Plasmid Kit (Macherey-Nagel) 
and polyethylenimine (Sigma-Aldrich) was used as transfection reagent the 
appropriate ratio of plasmid DNA to PEI was calculated with the online 
calculation tool: http://www.cytographica.com/lab/PEItransfect.html. Plasmid 
DNA was transfected to HEK-293 cells grown in a 25 cm2 flask and the cells 
were incubated for 24 hours before induction of protein expression. 
 
4.5 Western Blotting analysis 
Clone 2 cells were detached and centrifuged at 1200 RPM for 5 min, the pellet 
was resuspended in 20µL of RIPA buffer plus protease inhibitor.  After 7 min 
on ice, cells were resuspended by vortexing, then incubated on ice for 7 min 
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and resuspended again. Soluble proteins were separated by centrifugation at 
14000 g for 20 min at 4°C. The protein concentration was quantified by the 660 
nm Protein Assay Kit (PIERCE, Rockforfd, IL).  
The extracts were resuspended in 2X SDS sample buffer were and separated on 
a 8.5%  sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE). 
The Page Ruler Prestained Protein Ladder 10 to 170 kDa (Thermo Scientific ) 
was also loaded on the gel as a molecular weight standard.  
Proteins were then transferred to a polyvinylidene fluoride (PVDF) membrane 
by standard procedure. RPL expression (Ribosomal Protein) has also been 
evaluated as loading control. 
Membranes were blocked with 5% non-fat milk in TBS-T (10 mM TrisHCl, pH 
8.0, containing 150mM NaCl + 0.1% Tween 20) solution for 2 hours at room 
temperature (25°C). After washing with TBS-T , the membranes were incubated 
with a primary antibody directed against the  Strep- tag at 4°C on a shaker. 
After overnight incubation the membranes were washed with TBS-T, 
immunoblots were then incubated with a secondary HRP-conjugated anti-
mouse antibody 1:1000 (Cell Signaling technology, Danvers, MA, USA) and 
Strep-tagged proteins were visualized by using SuperSignal West Dura 
Extended Duration Substrate (Pierce Biotechnology, Rockford, IL, USA) 
according to the manufacturer’s instructions.  
 
4.6 Mitochondria isolation  
Cells were harvested by centrifugation (300gav, 4 min at 4°C) and resuspended 
in cold isolation buffer (IB) (210 mM mannitol, 70 mM sucrose, 5 mM Hepes-
KOH pH 7.2) with 0.25% BSA (fraction V). The cells were centrifuged again 
(300gav, 4 min at 4°C) and resuspended in IB (4mL/gram cells). Cells were 
permeabilized by addition of 20µl digitonin (1 mg/ml). After reaching the 
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permeabilization of 0.2-0.4 mg/mL by subsequent addition of 20μL digitonin, 
5mL of IB were added. The cell suspension was washed and then broken in a 
Dounce-homogeniser in ice. The pellet was resuspended in IB w/o BSA and cell 
debris were removed by repeated low speed centrifugation (1200 g for 3 min.). 
Mitochondria were collected by centrifugation of the remaining supernatant 
(3500gav for 20 min., 4°C) to obtain the heavy mitochondrial fraction and 
10.000gav, 10 min, 4°C, to obtain the light mitochondrial fraction.142 
The pellet containing mitochondria was resuspended in 1 mL of IB 
supplemented with ATP 0.5 mM, Succinate 0.2% and Pyruvate 0.01%.  
 
4.7 Spectrofluorimetric Analysis 
For the fluorescence spectroscopy measurement, uncorrected emission and 
corrected excitation spectra were obtained with a PTI Quanta Master C60/2000 
spectrofluorimeter (Photon Technology International, Inc., NJ, USA) and with 
PerkinElmer spectrofluorimeter. 
 
4.7.1 Measurement of mitochondrial magnesium uptake 
Loading of mitochondria with mag-fura 2-AM  
Loading was performed by incubating 1 mL of mitochondria suspension with 5 
μM of mag-fura 2-AM plus 1 μL of Pluronic (Eugene, OR) for 25 min at room 
temperature. After the incubation period, mitochondria were washed twice in 
IB w/o BSA to remove excess dye and resuspended in the same buffer 
supplemented with ATP 0.5 mM, Succinate 0.2% and Pyruvate 0.01%. 
Afterwards, the mitochondria were incubated for further 35 minutes to allow 
the complete hydrolysis of the dye, and washed twice prior to  the 
measurement. . Measurements were performed in 3 ml cuvettes with 2 ml cell 
suspension at 37°C in a spectrofluorimeter LS50-B (Perkin Elmer). Data  
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analysis was carried out by using the FL Win Lab version 3.0 (Perkin Elmer) 
according to Kolisek et al..42 
 
4.7.2 Quantification of total cell magnesium and cell volume determination 
Total magnesium content was assessed on sonicated cell samples by using the 
fluorescent chemosensor DCHQ5 assay as reported by Sargenti et al. 113 Briefly, 
DCHQ5 was dissolved to a final concentration of 15 µM in a mixture which 
contains 10% of DPBS in a solution 1:1 of MeOH:MOPS 2 mM (pH 7.4). 
Different amounts of MgSO4 were added and the fluorescence intensities were 
acquired at 510 nm. The total Mg2+ concentrations of the unknown samples 
were obtained by the interpolation of their fluorescence with the standard 
curve. 
To evaluate the mean cellular volume, Clone 2 cells were counted on a double-
threshold Z1 Coulter Counter (Beckman Coulter, USA) and the thresholds were 
set to cover the interval from 65 to 3,600 fl, each step corresponding to an 
increase of 2 μm in cell diameter. The mean cellular volume was estimated from 
the Gaussian distribution of the data. 
 
4.8 Microscopy Staining 
4.8.1 MRS2 overexpression 
Clone 2 cells were washed three times with PBS and then fixed using 2.5% 
paraformaldehyde in PBS for 20’ at room temperature. After washing with PBS, 
the cells were blocked in blocking buffer containing 10% (v/v) normal goat 
serum (NGS) in PBS. To determine the localization of MRS2, the cells were 
incubated for 1h at room temperature with the monoclonal Strep-tag primary 
antibody (1:500) (Qiagen). Bound anti-Strep was visualized with AlexaFluor-
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488- labeled goat anti mouse (1:500) (Invitrogen). The cells were sealed using 
mounting medium containing 4’,6 diamidino-2-phenylindole (DAPI), which 
stains nuclei and visualized with a fluorescence microscope. 
 
4.8.2 Apoptosis assay on fixed cells 
After 24 hours of induction with tetracycline, Clone2 cells were incubated with 
Staurosporine 2μM and Doxorubicin 2.5 μM for 6 and 17 hours respectively at 
37°C. The coverslips were washed 3 times in phosphate-buffered saline (PBS), 
fixed with 4% paraformaldehyde (Sigma, USA) in PBS and permeabilized with 
0.5% Triton X-100 (Sigma, USA) in PBS for 5 min at 4 °C. After 2 washes in PBS, 
sample were incubated in presence of Hoechst 33432 (Sigma USA) 1 μg/mL, 
washed and analyzed by fluorescence microscopy.(Zeiss Axioplan).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
 
4.9 Cell cycle analysis  
Clone 2 cells were detached with 0.11% trypsin (Sigma-Aldrich, St Louis MO), 
0.02% EDTA, washed twice in PBS and centrifuged. The pellet was suspended 
in 0.01% nonidet P-40 (Sigma, USA) 10 mg/mL RNase, and 0.1% sodium citrate 
(Sigma USA) and 50μ g/mL propidium iodide (PI) (Sigma, USA), for 30 min at 
room temperature in the dark. Propidium iodide fluorescence was analyzed 
using a Bryte HS flow cytometer (Biorad,UK) equipped with Hg lamp and 
analyzed with ModFit (Verity Software House, USA) software. 
 
4.10 Caspase Activity assay  
The activity of Caspase protease enzymes was measured by the cleavage of the 
fluorogenic peptide substrate AcDEVD-AMC that represents a substrate for 
caspase 3 and other members of the caspase family. At the indicated time points 
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(6 hours for STS treatment and 17 hours for DXR), cells were washed in 
phosphate-buffered saline, harvested in 0.1 ml of lysis buffer, and subjected to 
two cycles of freeze–thawing. The lysates were centrifuged for 10 min at 28,000 
× g at 4 °C and the supernatant was then used to assay in duplicate enzyme 
activity. Extract (10 μl) was incubated for 15 min at 37 °C in a final volume of 30 
μl to determine caspase activity as described in reference 143.143 
 
 
Part II 
 
4.11 Cell Culture and reagents 
Human colon carcinoma cells LoVo, sensitive (LoVo-S) and resistant (LoVo-R) 
to doxorubicin were cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
(Sigma), supplemented with 10% fetal bovine serum (FBS), 2 mM glutamine, 
100 units/mL penicillin, and 100 μg/mL streptomycin sulfate. LoVo 
doxorubicin-resistant cells (LoVo-R) were cultured under the same conditions 
and fed once every 2 weeks with 1 μg/mL doxorubicin. 
For atomic force microscopy and X-ray measurements, cells were plated at a 
concentration of 1 × 104 cell/cm2 on 1 × 1 mm2, 200-nm-thick silicon nitride 
(Si3N4) membrane windows, mounted on a 5 × 5 mm2 Si frame (Silson) 
previously sterilized in ethanol. Cells were incubated at 37 °C in 5% CO2 for at 
least 24 h. Two dehydration methods were then followed. In the first case, at 
50−80% confluency, cells were briefly rinsed in 150 mM KCl and then fixed in 
ice-cold methanol/acetone 1:1 and air-dried. In the second case, after being 
rinsing with 100 mM ammonium acetate, cells were cryofixed by plunge 
freezing in liquid ethane and then dehydrated in vacuum at low temperature 
overnight. 
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4.12 Flow cytometry  
Flow cytometric measurements were performed on a Bryte HS cytometer 
(BioRad, UK), equipped with a Hg lamp and a filter set with an excitation band 
centered on 360 nm and two emission bands centered respectively on 510 nm 
(DCHQ5 fluorescence) and 600 nm (propidium iodide fluorescence). Cells 
loaded with 5 μM DCHQ5 were counterstained with 5 μg/ml propidium iodide 
(PI) to identify dead cells. Fluorescence was recorded using a logarithmic scale.  
 
4.13 Quantification of total cell magnesium 
Total magnesium content was assessed on sonicated cell samples by using the 
fluorescent chemosensor DCHQ5 as reported in Sargenti et al. Briefly, DCHQ5 
was dissolved to a final concentration of 15 µM in a mixture which contains 
10% of DPBS in a solution 1:1 of MeOH:MOPS 2 mM (pH 7.4). To obtain 
standard curve, different amounts of MgSO4 were added and the fluorescence 
intensities were acquired at 510 nm. The Mg2+ concentrations of the unknown 
samples were obtained by the interpolation of their fluorescence with the 
standard curve, referred to the actual cell volume measured as described in the 
paragraph 4.16. 
 
4.14 Cell volume determination 
LoVo–S and LoVo-R detached by trypsinization, were centrifuged and 
resuspended in Phosphate Buffuer Saline (PBS) at the final concentration 
between 4000/mL and 8000/mL. 
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Cells volumes were calculated counting LoVo cells on a double-threshold Z1 
Coulter Counter (Beckman Coulter, USA) and the thresholds were set to cover 
the interval from 65 to 3,600 fL, each step corresponding to an increase of 2 μm 
in cell diameter. The mean cellular volume was estimated from the Gaussian 
distribution of the data. The analysis were carried out in triplicate 
 
4.15 Fluorescence and  Scanning Transmission X-Ray Microscopy  
analysis 
The X-Ray Fluorescence Microscopy (XRFM) and Scanning Transmission X-Ray 
Microscopy(STXM) measurements were carried out at the beamline Twinmic at 
Elettra Synchrotron (Trieste, Italy).  A Fresnel zone plate focused the incoming 
beam (1475 eV), monochromatized by a plane grating monochromator, to a 
circular spot of about 600 nm in diameter. The sample was transversally 
scanned in the zone plate focus, in steps of 500 nm. At each step the 
fluorescence radiation intensity was measured by eight Si-drift detectors (active 
area 30 mm2) concentrically mounted at a 20° grazing angle with respect to the 
specimen plane, at a detector-to-specimen distance of 28 mm. Simultaneously, 
the transmitted intensity T was measured by a fast-readout electron-
multiplying low-noise charge-coupled device (CCD) detector through an X-
ray−visible light converting system. Zone plate, sample, and detectors were in 
vacuum, thus avoiding any absorption and scattering by air 
Acquisition Protocol Dehydrated cells mounted on the Si3N4 membrane 
windows were carefully examined with optical microscope and selected 
following these criteria: integrity, dimensions (large cells require longer 
acquisition time), and distance from other cells (clustered cells have been 
avoided because AFM measurements require some free space around the cells). 
AFM measurements were performed on selected cells before and after XRFM 
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and STXM measurements. Five STXM images were acquired on whole cells 
with a step size of 500 nm. In sequence XRFM, and simultaneously also STXM, 
were carried out with a range of 6−8 s dwell time per pixel depending on the 
cell size. The total acquisition time was in the range of 5−8 h (field of view of at 
least 20 × 20 μm; spatial resolution 500 nm). The measurement of I0 is made on a 
part of the substrate free from cells, acquiring 25 points and repeating the 
measure five times. 
Mass Fraction and Concentration Calculation  
To obtain quantitative information from the measurement of fluorescence 
radiation, we used the fundamental parameter method. 
The mass fraction 𝑾   for each Mg2+ pixel p was calculated by the following 
expression : 
 
Eq.2 
 
where  𝝆 is the density, and 𝑭  is the correction factor for the selfabsorption of 
both incident beam and fluorescence radiation. 
Analogously, the concentration    in the single pixel p, expressed in molarity, 
is derived by the following expression: 
 
Eq.3 
 
where     is the mass expressed in molarity and 𝑨   is the atomic weight of 
the Mg2+ element.  
 
Statistical Analysis 
Differences of each experimental condition were evaluated by Student's t test and set as 
following: *p<0.05, **p<0.01.  
 𝑾𝑴𝒈(%) =
𝒅𝑹𝒊
𝝆 ∙ 𝑺 ∙ 𝒅𝒛 × 𝒀 𝑬𝟎,𝑴𝒈 × 𝑭𝒑
 
 𝑴𝑴𝒈 = 𝒘𝑴𝒈 ∙
𝟏
𝑨𝑴𝒈
 ∙  
𝒎
𝑽
∙ 𝟏𝟎𝟑 
 
   
 
 
5 RESULTS AND DISCUSSION  
 
 
Part I 
 
5.1 Cell system optimization  
The first part of this study was focused on creating highly-regulated and 
efficient expression of MRS2 gene. 
The human embryonic kidney 293 cells144 (HEK-293) were used as hosts for our 
gene of interest as they are a common model for the overexpression of 
recombinant proteins. The pcDNA6™/TR was used to generate a stable cell line 
which allowed us, in a second time, to express MRS2 by the solely addition of 
tetracycline. The pcDNA6™/TR is a 6.7 kb regulator vector designed for use 
with the T-REx™ System. Tetracycline regulation in the T-REx™ System is 
based on the binding of tetracycline to the Tet repressor (TR) and derepression 
of the cytomegalovirus (CMV) promoter controlling expression of the gene of 
interest (see figure 8). 140 
Surviving cell clones of HEK-293 cell  transfected with the pcDNA6™/TR, after 
appropriate selection with blasticidine, were picked and named Clone 2 and  
then used as a host cell line for our gene of interest MRS2.   
These resulting clones were overall healthy, propagated well and exhibited 
normal morphology as shown in figure 6 by the comparison with HEK-293 
from ATCC catalogue. 
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Figure 6 Morphology of  (A)HEK-293 cells wild type (microphotograph obtained by ATCC) 
and (B) HEK-293 cells stably transfected with vector pcDNA6™/TR named Clone2. Cell 
morphology was observed by visible light microscopy at magnification 20x.  
 
 
Firstly we performed a cell growth curves assay in order to evaluate the 
characteristic of cellular growth and to verify whether transfection could 
affected the normal cell proliferation of HEK-293 cells.  
Cell growth curves allowed us to determine the best time range for testing the 
effects of  the subsequent apoptotic inducing treatment. 
Figure 7 depicts the cellular-growth curves for HEK-293 cells and its transfected 
counterpart with pcDNA6™/TR, Clone 2, determined by counting cells every 24 
hours. 
A B 
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Figure 7 Cellular-growth curves for HEK-293 cells and Clone 2.  Evaluation of cell number at 
different hours of adhesion, using a Bürker chamber. All measurements were carried out by 
triplicate in three different replicates. 
 
The cell-line growth curves shows a “lag-phase” immediately after reseeding; 
the duration of this phase take near 24 hours.  
Subsequently, the cell enter into exponential growth, “log-phase”, in which the 
cell population doubles at a characteristic rate defined as doubling time which 
is characteristic for each cell line. This phase was chosen for the evaluation of  
drugs effects that stimulate or inhibit cell growth after MRS2 overexpression. 145 
It is possible to appreciate that HEK-293 and Clone 2 cells present the same 
trend as shown by doubling time, which is for both cell strains ~18hours.  
 
 
 
 
  Chapter 5- Results and Discussion 
61 
 
5.2  MRS2 overexpression 
 
MRS2 gene was cloned into the multiple cloning site of the inducible expression 
vector pcDNA™5/TO. This plasmid is a 5.7 kb expression vector specifically 
designed for use with the T-REx™ System and allows tetracycline-regulated 
expression of the gene of interest in mammalian host cells expressing the Tet 
repressor (TR) from the pcDNA™6/TR vector. In figure 8 are reported the 
plasmid maps of  the two vector used for inducible expression of MRS2. 
The pcDNA™5/TO vector contains hybrid promoter consisting of the human 
cytomegalovirus immediate-early (CMV) promoter and tetracycline operator 2 
(TetO2) sites for high-level tetracycline-regulated expression. 
In the absence of tetracycline, expression of the gene of interest is repressed by 
the binding of Tet repressor homodimers to the TetO2 sequences. Addition of 
tetracycline to the cells derepresses the hybrid CMV/TetO2 promoter in 
pcDNA™5/TO and allows expression of the gene of interest. 141 
After transfection, Clone 2 cells were treated with tetracycline 1µg/mL for 24 
hours to depress the hybrid CMV/TetO2 promoter in the expression vector and 
induce transcription of MRS2 gene.  
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Figure 8 Plasmid maps. The two components of the tetracycline-regulated mammalian 
expression system (Invitrogen's T-REx™ System) used to develop the Clone2  tetracycline 
inducible cell line are shown. On the top, the pcDNA™5/TO expression vector with the two 
tetracycline operator sequences (TetO2); on the bottom, the pcDNA™6/TR regulatory vector 
providing high-level expression of the tetracycline repressor (TR) protein and present in the 
Clone 2 control cell line.  
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The over-expression of the channel was checked by Western Blot analysis. The 
cells treated with tetracycline (lane B 5-7), show higher MRS2 expression 
compared to un-induced control cells (lane A 1-4), as reported in figure 9. As 
negative control, untransfected cells has also been loaded on the gel (lane 0) 
 
 
 
 
 
 
            
 
Figure 9 Comparison of MRS2 protein expression levels in the presence and absence of 
tetracycline 1µg/mL. Protein extracts were prepared after 24 hours from transfection with 
expression vector pcDNATM/5TO. (A) lane 1-4: transiently transfected  Clone 2 cell line; (B) lane 
5-7: transiently transfected Clone 2 cell line and induced with tetracycline resolved on reducing 
SDS–PAGE and analysed via Western blotting. Membranes were probed using an anti-Strep-
tag-II  monoclonal antibody (1:500 dilution) 
 
 
MRS2 induced expression was  confirmed by Immunocytochemistry: as shown 
in figure 10,  transfection with expression vector induces highly expression of 
the protein localized in the perinucelar region of  the cells treated with 
tetracycline 1µg/mL. A weak expression of the channel can also be detected in 
un-induced cells.  
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Figure 10 Morphological evaluation and expression of MRS2 in Clone 2 cells (A) and after 24 
hours by induction with tetracycline 1 μg/ml (B). Double labelling immunofluorescence of 
nuclei stained with DAPI (upper panel) and MRS2 (lover panel) stained with Strep-tag primary 
antibody (1:500) and visualized with AlexaFluor-488- labeled goat anti mouse (1:500).  
 
 
 
 
A B 
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5.3 MRS2 is mainly expressed in the heavy mitochondrial fraction 
 
MRS2 channel is a 55 kDa protein localized in the inner mitochondrial 
membrane. To examine the correct localization of the over-expressed MRS2 
protein, Clone 2 induced cells were studied for subcellular fraction experiments. 
Nuclear fraction and debris (Fig 11A, lane1), plasma-membrane (Fig 11A, 
lane2), heavy mitochondrial (Fig 11A, lane3) and light mitochondrial (Fig. 11A, 
lane4) fractions were separated by differential centrifugation. Each of the 
fractionated proteins were displayed by SDS-PAGE and analyzed by 
immunoblotting using antibodies to the strep-tag for MRS2 (Fig 11A, top panel) 
and Cytochrome c oxidase (COX) protein  terminal complex IV of the electron 
respiratory chain, as loading control for mitochondria. (Fig 11A, middle panel). 
In general, the heavy mitochondrial pellet contains, predominantly, 
mitochondria with rather few contaminants; minor components such as 
lysosomes, peroxisomes, Golgi membranes, and various membrane vesicles are 
still present. The light mitochondria pellet, contains mitochondria and other 
components such as lysosomes, peroxisomes, Golgi membranes and some 
endoplasmic reticulum.142 
MRS2 protein was mainly found to reside in the heavy mitochondrial fraction 
(Fig 11B, bar 3) which is consistent with the correct localization of MRS2 in the 
inner mitochondrial membrane.57  
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Figure 11 Isolation of human mitochondria from Clone 2 cells overexpressing MRS2  
Mitochondrial fractions were obtained by differential centrifugation A) Subcellular fraction of 
Clone 2 overexpressing MRS2 channel. The cells were fractionated into the nuclei (lane 1), 
plasmamembrane (lane 2), heavy mitochondria (lane3) and light mitochondria (lane 4) fractions 
by differential centrifugation. Proteins were analyzed by immunoblotting using antibodies to 
the strep-tag MRS2 (top panel), and COX IV for effective loading control of mitochondria 
(bottom panel). B) Relative Scanned Density of MRS2 in subcellular fractions. 
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5.4 Free magnesium uptake in isolated mitochondria 
Concentration of free Mg2+ in the matrix of mammalian mitochondria have been 
estimated to range between 0.2 and 1.5 mM. Since it has been published that 
steady state Mg2+ concentration of yeast mitochondria varied with the 
expression level of Mrs2p and that isolated mitochondria of eukaryotic cells 
respond to addition of external Magnesium in function of MRS2 expression, we 
determined changes in Mg2+ ion concentrations by continuous fluorescent 
recording over time.  
By using the ion sensitive fluorescent dye membrane-permeant acetoxymethyl 
ester (AM)  of the Mg2+ sensitive fluorescent dye mag-fura 2, we have 
performed ratiometric measurements of free Mg2+ concentration in isolated 
human mitochondria essentially following the protocol by Kolisek et al.42 
Heavy mitochondrial fraction were isolated from Clone 2 cells induced and 
uninduced with tetracycline and transferred into a nominally Mg2+ -free 
solution for dye loading. 
Figure 12 shows the ratiometric measurements corresponding to the 
fluorescence ratio of the original acquisition collected respectively at 340 and 
380 nm excitation wavelengths which are in turn the standard excitation 
wavelengths for the ion-bound and free mag-fura2.  
When external MgCl2 was added stepwise to 1 and 3mM an increase of the 
fluorescent intensity ratio occurred, indicating ion passing across the 
mitochondrial membranes.  However, mitochondrial magnesium increasing is 
markedly higher in cells overexpressing MRS2 channel upon addition of 3 mM 
MgCl2. 
This data is in agreement with that reported in yeast by Kolisek et al., showing  
the capability of mitochondria to internalize Mg2+ by using the MRS2 channel 
with a rapid high capacity influx mechanism. 
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Figure 12 Determination of free Mg2+ in isolated mitochondria. Mitochondria isolated from 
Clone 2 were loaded with the Mg2+-sensitive dye mag-fura 2. Changes in the free Mg2+ 
concentrations over time were determined upon raising extra-mitochondrial Mg2+ 
concentrations from nominally 0 mM to 1 mM, and from 1 mM to 3 mM. Blue line:Clone 2 
control cells; Red line: Clone 2 cells overexpressing MRS2. Note the difference in the slopes of 
the tracings from the two mitochondria types, reflecting that Mg uptake rates depend on MRS2 
expression. 
 
5.5 MRS2 overexpression induces increment of magnesium total 
concentration  
Total Mg2+ concentration is composed of a large fraction of bound Mg2+ and a 
small fraction of free Mg2+. Mitochondria represent the major Mg2+ store in the 
cell and mitochondrial Mg2+ pools may be mobilized to buffer cytoplasmic 
concentration of the cation. Aimed to verify whether up-regulation of MRS2 
channel could also have an influence on the intracellular total Magnesium 
MgCl2 3mM 
MgCl2 3mM 
MgCl2 1mM 
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content we exploited the characteristic of DCHQ5, a new fluorescent 
chemosensor able to quantify total Mg2+ in sonicated cell.113  
To express total Magnesium amount as mM concentration, we calculated the 
volume of Clone 2 cells. 
 
Immediately after trypsinization, Clone 2 cells were counted and resuspended 
at the final concentration of 10000/mL in 20 mL final volume of PBS. 
Cells were analysed by using a double-threshold Z1 Coulter Counter as 
reported in the “Material and methods” section and the frequency distribution 
of Clone 2 cell volumes is reported in figure 13. The mean cellular volume has 
been calculated to be 1,17E+03 fL 
 
 
Figure 13 Gaussian distribution of Clone 2 cells volume. 
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 DCHQ5 fluorescence intensity was acquired at 510 nm upon excitation at 360 
nm, and the Mg2+ concentration of the unknown samples were obtained by the 
interpolation of their fluorescence with the standard curve as described in 
Sargenti et al. Measurements of total cellular Mg2+ revealed statistically 
significant increase of its concentration in clones over expressing MRS2 channel.  
As shown in Figure 14 total intracellular magnesium content in cells 
overexpressing MRS2 is 65.38±4.92 mM, three times more than in control cells, 
which present an average concentration of 22.47±2.03 mM. 
Quantification of total intracellular Mg2+ by using DCHQ5 allowed us to reach 
unprecedented result and to demonstrate for the first time that MRS2 protein 
overexpression is able to induce an increment of the total intracellular Mg2+ in 
human cells. We hypothesize that this increased amount of magnesium is due 
to the high capability of MRS2 to retrieve Mg2+ in mitochondria.  
 
 
Figure 14 Fluorimetric analysis of total magnesium content in Clone 2. Measurement were 
carried out in sonicated sample by using the fluorescent probe DCHQ5 in Clone 2 cell control 
(CTRL) and overexpressing MRS2 protein (MRS2). 
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5.6 MRS2 overexpression protects from apoptotic stimuli 
Many aspects of Mg2+ biochemistry indicate a role for this cation in the 
apoptotic process sustained by the fact that mitochondria which are the key 
organelle in the onset of apoptotic programme are the main intracellular Mg2+ 
store.87  
In particular, it has been proposed a link between apoptosis and Mg2+ 
mitochondrial channel MRS2. MRS2, by promoting Mg2+ uptake, potentiates 
mitochondrial energetic function, which sustains both pump activity, by Mg2+-
ATP2-, and cell proliferation. 
To verify this hypothesis we induced cell death in Clone 2 cells overexpressing 
MRS2 protein by two common pro-apoptotic drug stimuli: doxorubicin (DXR) 
and staurosporine (STS) 
 
 
5.6.1 Effect of MRS2 overexpression during DXR induced apoptosis 
Doxorubicin is a well-known chemotherapeutic agent used in treatment of a 
wide variety of tumours. Its interaction with cellular DNA along with apoptosis 
activation via intrinsic pathway is believed to be the principal mechanism of its 
biological activity. 146 
The ability of doxorubicin to affect cell viability and apoptosis induction was 
initially confirmed by morphological evaluation. After incubation with DXR 
2.5μM for 17 h, morphological alterations in Clone 2 cells, induced and 
uninduced with Tet, were observed in bright field in comparison to control 
cells. As shown in figure 15, control cells showed their typical morphology, 
appearing adherent to the tissue culture dishes and with several nucleoli. In 
contrast, exposure of Clone2 cells treated with DXR revealed typical apoptotic 
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features such as rounding, shrinkage and losing contact with adjacent cells. 
Finally, DXR treatment on the cell induced with tetracycline 1µg/mL and 
overexpressing MRS2 channel present more similar morphology to untreated 
cells with more adherent cells to the culture dishes and rare rounding cells. 
 
 
Figure 15 Morphological evaluation of Clone 2 cells treated with DXR 
Clone 2 cells, induced(+MRS2+DXR) and un-induced (DXR) with Tet were treated with DXR 
2.5µM for 17 hours after induction. Untreated cell is also show as control. 
 
 
Clone 2 cells, were subjected to fluorescence microscopy evaluation by staining 
nuclei with Hoechst 33342 to check the presence of nuclear condensation and 
DNA fragmentation typically occurring in apoptosis. Coverslips with adherent 
Clone 2 and treated with DXR 2.5µM after 17 hours were fixed with 3.7% 
paraformaldehyde and stained with Hoechst 33342 (1 μg/ml).  
As depicted in figure 16, the untreated control cells displayed normal, round 
nuclei (CTRL) as well as MRS2 overexpressing cells treated with 
DXR(+MRS2+DXR), while Clone2 cells treated with DXR exhibited 
characteristics of apoptosis, such as cell shrinkage and nuclear condensation 
(DXR).  
 
 
 
 
 
Untreated +DXR +MRS2+DXR 
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Figure 16 Morphological evaluation of DNA fragmentation and Chromatin condensation of 
Clone 2 cells after treatment with DXR upon MRS2 overexpression. Clone 2 cells Control 
(CTRL), treated with doxorubicin 2.5µM (DXR) and Clone 2 overexpressing MRS2 channel 
treated with doxorubicin 2.5µM (+MRS2+DXR) were grown on glass coverslips, and detached 
17 hours after treatment. 
Cells were fixed with paraformaldehyde 3.7% and nuclei were stained with Hoechst 33342 and 
subjected to fluorescence microscopy. Images reported are from one experiment representative 
of three that gave similar results.  
 
 
Since it is largely known that doxorubicin treatment affects cell cycle 
progression we investigated whether the MRS2 expression could also have an 
influence on DNA content during apoptosis induction by DXR.  
To accomplish this task we choose two different DXR concentration as it is 
reported that effect of DXR on cell cycle is highly dependent on the dose of 
treatment.147 
Clone 2 cells control and overexpressing MRS2 channel were exposed to 
doxorubicin 2.5 and 5 µM As shown in figure 17 A both doses of doxorubicin 
affect cell cycle progression of Clone 2. The lower dose of 2.5 µM induces a 
remarkable increase in cells residing in S to G2-M phase. The increased dose 
DXR(5 µM) resulted in a depletion of cells in S to G2-M phase that can be 
explained by a massive apoptosis in particular in these phases.  
Untreated 
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As the apoptotic cells with fragmented nuclei appear as cells with hypodiploid 
DNA content and could be detected at sub-G1 peak with flow cytometry, the 
numbers of the apoptotic sub-G1 population were quantified.  
The results demonstrated that the DXR treated Clone2 samples had 
significantly increased in the sub-G1 phase as compared to the untreated 
sample and to sample treated but overexpressing MRS2.  
Furthermore, in control cells the sub-G1 populations increased in dose 
dependent way, from 3,09 % in untreated cells to 16.47 % and 76.74% 
respectively in cells treated with  2.5 µM and 5 µM DXR.  
On the contrary, in cells over-expressing MRS2 the influence of  doxorubicin on 
cell cycle is very weak and minor dependent of the dose (figure 17 B) We can 
observe a slight increase of cells in the S and G2/M phase when these cells were 
treated with 2.5 DXR. However, this weak effect disappear at the highest dose 
of 5 µM which did not induce variation of DNA content respect to untreated 
cells. 
These results indicate that apoptosis is the cell death mode of DXR in Clone 2 
cells and most of all that MRS2 prevent from this drug effect on cell cycle 
progression. 
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Table II Percentage of cells cycle distribution in Clone 2 cells treated with DXR 2.5 and 5µM. 
 
 
 
 
 
 
 
 
 
 
 
 
Table III Percentage of cells cycle distribution in Clone 2 cells overexpressing MRS2 channel 
treated with DXR 2.5 and 5µM. 
 
Figure 17 Flow cytometric analysis of Clone 2 (A) control cells and (B) overexpressing MRS2 
channel. treated with doxorubicin (DXR). Cells were harvested at 17 h after 2.5 and 5 µM DXR 
treatment and collected in a citrate buffer. Then, RNA was digested and DNA content was 
stained with propidium iodide(PI). Cell cycle distribution was determined by flow cytometry. 
The histograms reports DNA content (expressed in fluorescence channels) versus the number of 
acquired events. DNA content is directly proportional to PI fluorescence.   
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Apoptosis is a process of active cellular self-demolition that requires the 
expression of specific genes. Despite the diversity of signals that can induce cell 
death, these pathways share several features in their execution. One 
mechanism, which is consistently implicated in apoptosis, reflects an 
orchestrated series of biochemical events that is carried out by a group of 
cytosolic proteases, named caspases. Activation of these protein is considered 
one of the hallmark of triggered apoptosis. Thus, inhibition of the activity of 
caspase-3 might protect cells from apoptosis. 
We tested the activity of executioner caspases in order to demonstrate that 
MRS2 truly prevent from DXR cell death induction. In particular we evaluated 
the DEVDase activity of caspase 3/7 after treatment with DXR 5 µM . 
As expected, DXR significantly increased caspase activity in control cells.146 On 
the contrary, MRS2 overexpressing cells respond to DXR exposure with a lower 
activation of these proteins. (Figure 18)  
Figure 18 Caspase Activity assay. The activity of caspase proteases (DEVDase activity) was 
measured fluorimetrically in Clone2 cells control and overexpressing MRS2 channel after 
treatement with 5μM DXR for 17 h. * Indicate significantly difference P< 0.05   
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5.6.2 Effect of MRS2 overexpression during STS induced apoptosis 
Staurosporine is a strong inhibitor of Protein kinase C widely used as 
therapeutic agent in tumour treatment for its ability to activate intrinsic 
apoptotic pathway. 148 
We used this drug as established known inducer of apoptosis to confirm the 
results previously obtained with DXR.  
Clone 2 cells were treated with STS 2 µM and after 6 hours of treatment were 
analysed by fluorescence microscopy to evaluate the typical morphological 
changes of apoptosis such as reduction of cell volume and nuclear 
fragmentation 
As illustrated in Figure 19, Clone2 cells incubated with STS exhibited many 
more cells with condensed and fragmented nuclei than those treated with STS 
and overexpressing MRS2 channel. This latter appear more similar to untreated 
cells.  
 
 
 
 
 
 
 
Figure 19 Morphological evaluation of DNA fragmentation and Chromatin condensation of 
Clone 2 cells after treatment with Staurosporine (STS) upon MRS2 overexpression. 
Clone 2 cells Control (CTRL), treated with STS 2µM (STS) and Clone 2 overexpressing MRS2 
channel treated with staurosporine 2 (+MRS2+STS) were grown on glass coverslips, and after6 
hours after treatment. Cells were fixed with paraformaldehyde 3.7% and nuclei were stained 
with Hoechst 33342 and subjected to fluorescence microscopy. Images reported are from one 
experiment representative of three that gave similar results.  
 
Untreated 
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To further investigate the STS triggered apoptosis upon MRS2 overexpression, 
Clone2 cells were then subjected to flow cytometric analysis. 
In particular, we monitored the effect of staurosporine on cell cycle distribution. 
Indeed, the predominant effect of staurosporine is to induce block of cell cycle 
in the G2/M phase.148 
Effects of staurosporine were detected by comparing the cell cycle profiles 
between treated and untreated cells. Results, showed in figure 20 A, 
demonstrates a decrease of the G0/G1 phase with a concomitant increase in the 
G2/M phase in treated cells. Moreover, the sub-G1 peak is detectable. These 
results confirmed the cell cycle arrest at the G2/M checkpoint as the major effect 
of this molecule on DNA content and the triggering of apoptosis evidenced by 
sub-G1 peak. The percentage of cells in the S, G1, and G2/M phases are shown 
in Table IV. 
In figure 20 B are reported cell cycle profile of Clone 2 cells overexpressing 
MRS2 treated and untreated with STS 2 µM. Notably, cells do not show the 
typical G2/M arrest induced by this drug, but even the G0/G1 phase is more 
pronounced respect to untreated cells with ~71% of cells in this phase.  
This result evidence that STS may affect cell cycle in MRS2 positive cells with a 
less extent and by a different mechanism. Furthermore, this data would be 
fitted in the complex network of cellular signals and give an indirect insight 
into the relationship between Magnesium and protein kinase C. Indeed, the 
main pathway for Mg2+ accumulation in mammalian cells is the activation of 
protein kinase C (PKC). Moreover it has been shown that the neuroprotective 
role of Magnesium against damage to synaptic transmission may include 
altering the PKC response to anoxic insults. It seems that magnesium induce the 
translocation of PKC to the membrane cytoskeleton and to augment its 
activity.149 
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Table IV Percentage of cells cycle distribution in Clone 2 cells treated with STS 2µM. 
 
   
 
 
 
 
Table V Percentage of cells cycle distribution in Clone 2 cells overexpressing MRS2 channel 
treated with STS 2µM. 
 
 
Figure 20 Flow cytometric analysis of Clone 2 (A) control cells and (B) overexpressing MRS2 
channel. treated with staurosporine(STS). Cells were harvested at 6h after 2 µM STS treatment 
and collected in a citrate buffer. Then, RNA was digested and DNA content was stained with 
propidium iodide. Cell cycle distribution was determined by flow cytometry. The histograms 
reports PI fluorescence (expressed in fluorescence channels) versus the number of acquired 
events. PI fluorescence is directly proportional to DNA content.  
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To deepen the effect of staurosporine on Clone 2 cells overexpressing MRS2 
channel we evaluate the activity of executioner caspases-3/7 after treatment 
with STS.  
Our results reveals an increased caspase activity in control cells after exposure 
with staurosporine 2 µM. Although with a less extent, respect to DXR 
treatment, MRS2 overexpression induce a less responsiveness of executioner 
caspases upon staurosporine treatment. (Figure 21)  
Since MRS2 overexpression seems to interfere with the caspase-3/7 activity in 
the Clone 2 cells, it has the capacity to attenuate the effect of STS induced 
apoptosis. 
 
              
 
 
Figure 21 Caspase Activity assay. The activity of caspase proteases (DEVDase activity) was 
measured fluorimetrically in Clone2 cells control and overexpressing MRS2 channel after 
treatement with 2μM STS for 6 h.* P<0.05 
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Part II 
 
Basic and pre-clinical studies indicate that a relationship between magnesium 
and cancer exists and that magnesium deficiency can have both anti- and pro-
tumour effects. 99 In particular, recent evidences pointed out a role for Mg2+ in 
resistance of cancer cells to antitumor drugs. The acquired resistance to a single 
anticancer agent is frequently accompanied by the development of cross-
resistance to multiple drugs. This phenomenon, known as MDR appears to be 
due to a reduced net intracellular drug accumulation resulting from 
overexpression of specific protein acting as efflux pumps. 106 
Considering the established role of Mg2+ in cell metabolism its deregulation in 
cancer cells is reflected into impaired intracellular Mg2+ concentration, 
compartmentalization and distribution potentially leading to MDR phenotype. 
In the second part of this research, we aimed to verify if intracellular Mg2+ 
content could be used as a feature to distinguish MDR cell phenotype from 
their sensitive counterpart. 
 
5.7 MDR cell phenotype 
Firstly we performed a cell growth curves assay to compare cellular  growth  of 
the two cellular strains understudy: colon adenocarcinoma cell line sensitive 
(LoVo-S) and resistant to doxorubicin (LoVo-R). Resistant cells were growth 
retarded when compared to sensitive ones (Fig. 22A). In particular, while LoVo-
S started to double 24 hours after seeding, LoVo-R entered the exponential 
phase after 48 hours. These results were further investigated by analyzing cell 
cycle distribution by flow cytometry . Figure 22B shows that the percentage of 
LoVo-S in the S phase started to decrease at 96 h, after reaching confluence. On 
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the contrary, in LoVo-R the S phase was still maximal after 96 hours from 
seeding and began to decrease only at 168 hours (Fig. 22B). Thus, the amount of 
cells in S phase directly correlates with the proliferation rate of the two cell 
lines. 
 
 
 
Figure 22 Comparison of  cellular growth curve(A) and cell cycle analysis(B) of LoVo-S and 
Lovo-R cells. Evaluation of cell number at different hours of adhesion, using a Bürker chamber. 
All measurements were carried out by triplicate in three different replicates.Cell cycle analysis 
were carried out by using flow cytometer. Both cell strains  incubated with the DNA-staining 
chemical propidium iodide for DNA content-based assessment of cell-cycle distribution.  
 
5.7.1 Magnesium intracellular concentration is higher in resistant cells 
It is well known that tumour cells present the peculiarity to accumulate Mg2+ 
with higher extent respect to non-tumour cells.13 To characterize Mg2+ profile of 
LoVo cells, we analyzed the intracellular magnesium content in viable cell by 
using DCHQ5 chemosensor. DCHQ5 belongs to a family of fluorescent 
hydroxyquinoline derivatives showing a remarkable affinity and specificity for 
magnesium, higher than the other commercially available probes. 
In particular, this probe allows a versatile flow cytometric semi-quantitative 
determination of total magnesium concentrations in whole cells, being excited 
in UV and the visible field. Furthermore, DCHQ5 chemosensor allows 
multiparametric analysis beings capable to selectively stain live cells and 
A B 
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resulting well tolerated by the cells at loading concentration of 5µM and 
incubation time up to 30 minutes.150  
LoVo-S and LoVo-R cells loaded with DCHQ5 and counterstained with PI were 
analysed by flow cytometry to discriminate live from damaged cells and 
selectively analyse intracellular Mg2+ content. 
Figure 23 reports the cytograms of LoVo cells: PI positive/damaged cells 
(quadrant A) are distinct from DCHQ5 fluorescent cells (quadrant D), 
suggesting that DCHQ5 selectively stains live cells.  
 
 
  
 
 
 
 
Figure 23 Cytograms of LoVo S (left) and LoVo-R (right) cells loaded with DCHQ5 and PI  
analysed after 15 min of incubation at room temperature. Quadrant A: PI positive/damaged 
cells with low DCHQ5 fluorescence; quadrant C: PI negative/viable cells with low DCHQ5 
fluorescence; quadrant D: PI negative/viable cells with high DCHQ5 fluorescence. The 
percentage of cell population is indicated in each quadrant. Cells were resuspended at the 
concentration of 5×105/ml; DCHQ5 5 μM; PI 5μg/mL. Results from a typical experiment 
repeated three times with similar results 
 
 
 
 
LoVo-S LoVo-R 
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Our data shows a different fluorescence intensity of DCHQ5 in live cells 
pertained to the two cell strains, indicating that LoVo-R cells present higher 
Mg2+ amount.  
Magnesium levels were then correlate with cell dimension by integrating 
DCHQ5 fluorescence intensity of live cells to forward scattering signal (FS). Cell 
dimension was estimated by detecting forward scattered light in the direction 
of the laser path and analysing the signal. 
Histograms of DCHQ5 fluorescence and of FS of LoVo sensitive and resistant 
cells are showed in figure 24.  
Analysis of the aforesaid histograms are reported in table VI: LoVo-R present 
higher Mg2+ content compared to LoVo-S cells presenting a mean channel for 
DCHQ5 fluorescence of 864.03 respect to 698.11. 
Although LoVo-R cells show higher Mg2+ levels than LoVo-S cells their 
dimension seems to be reduced displaying a FS mean intensity channel one 
third slighter compared to LoVo-S cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
  Chapter 5- Results and Discussion 
85 
 
 
 
 
 
 
 
 
 
 
 
Figure 24 Cytograms of LoVo S (left) and LoVo-R (right) cells. In the upper panel (A) are 
reported the flow cytometric  histograms of LoVo-S and Lovo R cells stained with DCHQ5 5µM 
to evaluate Mg intracellular levels.  In the lower panel (B) are reported representative FACS 
histogram showing Forward Scattering (FS) of LoVo-S and Lovo-R cells. Forward light scatter 
was considered a function of cell size. Typical histograms of at least three independent 
experiments.  
LoVo-S LoVo-R 
A 
B 
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Table VI Mean channel of FS and DCHQ5 fluorescence in LoVos and LoVo R cells. 
Taking into account the information given by flow cytometric analysis, we 
performed quantitative spectrofluorimetric assay with DCHQ5 in order to 
quantify the total Mg2+ concentrations in a large cell population. As expected for 
hydroxyquinoline derivatives, DCHQ5 fluorescence is affected by membrane-
defined intracellular compartments.114 In order to prevent false positive of 
fluorescence intensity due to the interference of lypophilic structure of the 
cellular membranes, the cells were exactly counted and sonicated prior to 
perform the fluorimetric assay.  
Furthermore, we calculated the exact volume of LoVo-S and LoVo-R cells by 
using Beckman coulter counter because Mg2+ intracellular concentration is 
significantly influenced by cell dimension. 
As shown by Gaussian distribution of cell volumes, represented in figure 25, 
sensitive cells are bigger respect to resistant cells. Moreover, while the volume 
of LoVo-R cells present a typical Gaussian distribution with mean calculated 
value of 1380 fL, LoVo-S cells are more homogeneous presenting a large part of 
the analysed population with high ratio for number of cells per interval. In this 
case the mean cellular volume has been calculated to be 1600 fL. 
  FS mean channel DCHQ5 mean channel 
               LoVo-S 920.22 541.98 
 LoVo-R 698.11 864.03 
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Figure 25 Gaussian distribution of LoVo –S and Lovo-R cells. 
 
Therefore, we normalized the amount of magnesium assessed by fluorimetric 
assay to the calculated cells volume, thus providing molar concentration of total 
intracellular Mg2+.  
Histogram reported in figure 26 represents the total intracellular magnesium 
concentrations in the two cell strains after 24 hours of adhesion. Resistant cells 
contain statically significant more total Mg2+ concentration than sensitive cells 
presenting an average concentration of 24±2.03 mM compared to 19.10±1.45 mM 
of LoVo-S cells. 
This result is in agreement with that reported by Marverti et al. founding 
increased amount of Mg2+ in cis-platin resistant human ovarian carcinoma cell 
line (C13*) compared to sensitive cells.112 This difference can attributed to a 
different expression pattern of Mg2+ transporters. In particular, the 
mitochondrial Mg2+ transporter MRS2 has recently gaining increasing attention 
for its involvement in MDR cell phenotype. Since an up-regulation of this 
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channel has been found in gastric cancer cells resistant to doxorubicin it would 
be interesting to investigate whether it has different expression also in LoVo R 
respect to LoVo-S cells.  
It is worth noting that our obtained data refers to the time in which the cells 
have adhered and are beginning to proliferate.  
Role of Mg2+ in regulating cell proliferation is well established. Coherently with 
the promoting role of Mg2+ on protein and DNA synthesis, proliferating cells 
contain more Mg2+ than resting ones and  require appropriate Mg2+ level to 
occur.  
Among Mg2+ transporters, Transient Receptor Potential Melastatin 7 (TRPM7) 
channel, has reported to regulate cell proliferation and invasion of cancer cells. 
Although TRPM7 represents the major magnesium-uptake mechanism in 
mammalian cells and its over-expression has been found in a variety of human 
carcinoma cells, no data are available about the expression of TRPM7 in drug 
resistant tumour cells so far.50 However, unpublished data of our collaborators 
indicate a different expression of TRMP7 channel in colon cancer LoVo cells 
sensitive and resistant to doxorubicin. 
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Figure 26 Total Mg2+ concentrations of LoVo-S and Lovo-R cells. Magnesium intracellular 
concentration was evaluated fluorimetriccly by using DCHQ5 chemosensor in sonicated 
samples. * Indicate a P value ~ 0.02 
 
 
5.7.2 Different magnesium intracellular distribution pattern in drug-
sensitive and -resistant cells 
With the continuous development of analytical techniques providing complex 
information at single cell level, the study of cell heterogeneity has been the 
focus of several research projects within analytical biotechnology.  
However, in Mg2+ field there is a lack of information about the exact 
intracellular concentration and distribution of this element. 
By adopting a multidisciplinary approach, with the use of complementary 
techniques and implementation of custom-made algorithms, we reached the 
challenging issue to obtain molar concentration maps of Mg2+ in whole single 
cell. To do this we combined  Atomic Force Microscopy (AFM), with 
synchrotron based X-ray fluorescence Microscopy (XRFM) and Scanning 
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Transmission X-ray Microscopy (STXM), in Lovo-S and LoVo-R fixed cells. 
Atomic Force Micrsocopy measurements gave us morphology information 
(thickness)  providing the volume of each single cell analysed. The volume of 
the dehydrated cells has been estimated 166 fL for LoVo-S cells and 142 fL for 
LoVo-R cells. The merger of all of these techniques (multimodal fusion 
approach) permits to have all the information necessary to draw the 
intracellular elemental maps of mass fraction and molar concentration of Mg2+ 
(Figure 27). In particular, molar concentration  distribution were obtained by 
normalizing the maps of fluorescence intensity respectively to volume maps 
(see eqs 2 and 3 of Materials and Methods). This accurate approach provides 
both submicrometer spatial resolution and quantification of elements down to 
106 atoms/ μm3 (based on the minimum Mg2+ concentration detected in a single 
pixel, i.e., 1 mM).  
 
                                     
Figure 27 Morphology and concentration map human of colon carcinoma LoVo-R (left) and 
LoVo-S (right). Total Mg2+ concentration maps evaluated by matching AFM, XRFM and STXM 
given information. 
 
 
It is worth noting that the comparison between LoVo-R and LoVo-S cells 
revelead different patterns in the spatial distribution of Mg2+ concentration. 
LoVo-R cells present the highest values of molar concentration within the 
nucleus and in the perinuclear region, where most of intracellular organelles 
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and particularly mitochondria, are located. This is in agreement with the 
experimental evidences that mitochondria are the major intracellular 
magnesium stores inside the cells. 
On the contrary, LoVo-S cells showed the highest value in the cytoplasmic 
periferal region. It can be hypothesized that this different spatial distribution 
between the two cellular strains could reflect the different metabolic activity of 
LoVo-R cells respect to their sensitive counterpart. Considering the well known 
role of MgATP2- in buffering Mg2+ intracellular content, it has been postulated 
that the levels of Mg2+ binded to ATP represent a key parameter in regulation of 
protein synthesis and cell proliferation leading to neoplastic transformation.88 
Moreover, efflux pumps characterizing the MDR phenotype, belong to ATP 
binding cassette protein family and need energy to function; in this scenario it 
has to be consider that Mg2+-ATP2− is the only active form of ATP. Therefore 
higher intracellular Mg2+ concentration is coherent with the idea that an increase 
energy demand is required to potentiate mitochondrial energetic function and 
consequently the activity of efflux pumps, which are highly dependent from 
ATP.103 
Subsequently, combining volumetric information obtained by AFM 
measurements  with STXM we calculate Mg2+ molar concentration of 
dehydrated cells. 
As shown in figure 28, in a population of 14 LoVo-S cells and 13 LoVo-R single 
cells, different distribution of Mg2+ concentration values  were detected. The 
amount of total intracellular Magnesium has been calculated to be 55±27 mM 
and 88±38mM for the two strains respectively. It is worth  noting that trend of 
Mg2+ concentration found in single cell population is of the same order of 
magnitude to that previously found in large cell population with DCHQ5 assay. 
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Figure 28 Single cell population analysis of Total Mg concentrations in LoVo-S and Lovo-R 
cells. Magnesium intracellular concentration was evaluated by synchrotron radiation referring 
to volume of dehydrated cells previously calculated by AFM. The black bar represent mean 
channel value. 
 
 
Although, we used cryogenic methods of fixation to preserve the chemical 
integrity of the cell and its morphology, this method of fixation as well as all the 
other available methods, presents the inconvenience of reducing cellular 
volume. The decrement of cellular volume can be attributed to the loss of H2O 
inside the cells. 
Therefore, aimed to reach the exact value of molar concentration in our fixed 
cells we decided to refer the total amount of Mg2+ found in single dehydrated 
cells to the volume of hydrated cells calculated by Beckman Coulter Counter 
(see figure 25). Histograms reported in figure 29, displays the comparison 
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between large cell population data and single cells data of the Mg2+ intracellular 
concentration found both in sensitive (purple) and resistant (green) cells. It is 
worth underlining that single cells data are almost overlapping those obtained 
in large cell population.  
It is confirmed that LoVo-R cells show a relevant increase of Mg2+ concentration 
compared to LoVo-S.  
 
 
 
Figure 29 Comparison of Total Mg2+ concentrations in LoVo-S and Lovo-R cells assessed by 
two different techniques: DCHQ5 spectrofluorimetric assay and XRFM multimodal 
approach. Magnesium intracellular concentration was evaluated by DCHQ5 fluorescence and 
synchrotron radiation referring to volume of hydrated cells.*  P~0.02  ** P<0.01  
 
 
  
 
6 Conclusions 
Magnesium is a critical cofactor of many enzymatic reactions important for 
physiological functions, such as nucleic acid metabolism, protein synthesis and 
energy production. Growing evidences point to a possible role for this cation in 
the apoptotic process but the available literature is still scarce and 
contradictory. Nevertheless, both intrinsic and extrinsic pathways of apoptosis 
are accompanied by variations in cytosolic magnesium, and magnesium 
appears to be required for the release of cytochrome c from isolated 
mitochondria. Given the central role of mitochondria in apoptosis, their ion 
channels are emerging as promising targets for cancer treatment. As a 
consequence of changes in ion flux across the inner mitochondrial membrane, 
alterations of mitochondrial function occur that produce severe effects on the 
overall health, including ATP production, of these organelles.138 In this regard, 
the presence of a Mg2+ selective influx channel in mitochondria (MRS2) 
suffrages the hypothesis of the involvement of magnesium in the apoptotic 
onset.  
The study herein reported is the first on the effect of regulated expression of 
mitochondrial Mg2+ channel MRS2 on induced apoptotic cells.  
Clones derived from HEK-293 cell line, died within a few hours after inducing 
apoptosis, as revealed by cell cycle analysis, nuclear condensation, DNA 
fragmentation and cleavage of cysteinyl proteases. On the contrary, cells 
overexpressing MRS2 protein were more resistant to all the apoptotic stimuli 
performed.  
The underlying mechanism of this effect may still relate to the role of MRS2 
protein in the regulation of mitochondrial functions. The concept of a possible 
network between drug sensitivity and mitochondrial function, morphology and 
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or localization is not conceptually new. Mitochondria are known to take active 
part in the apoptotic process by various mechanisms including release of 
caspase activators, disruption of electron transport and energy metabolism, and 
production of reactive oxygen species. In conclusion, the fact that activation of 
the mitochondrial death pathway represents the major mechanism of most 
conventional anticancer drugs, including DXR and STS, could explain why cells 
overexpressing MRS2 channel overcome the induced apoptosis.  
However it has to be point out that cell cycle progression of cells 
overexpressing MRS2 and treated with STS appeared to be more affected by the 
drug compared with DXR treatment, this could due to the possibility to the 
triggering of a different apoptotic pathway independent from caspases 
activation.151 
Further investigations are needed to evaluate the biological role of Mg2+ in 
resistance to anticancer drugs by promoting the cells to overcome apoptosis 
signal.  
Moreover, we showed for the first time that overexpression of mitochondrial 
Mg2+ influx channel MRS2 induces an increment of total intracellular Mg2+. 
However, recent findings report a new mitochondrial magnesium transporter 
in yeast, the Mme1 protein that seems to act as a magnesium exporter.152 In this 
contest, it will represent a challenging task to investigate whether this export 
mechanism is also expressed in our experimental model. 
Obviously, these findings open a multitude of questions upon the functional 
implications of MRS2 protein in Mg2+ perturbation associated diseases..  
 
 In the second part of this research, we studied Mg2+ distribution and 
concentration in MDR cell model together with the possibility to give new 
insight into Mg2+ quantification.  
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 The main goal of the research was to verify whether magnesium intracellular 
content and compartmentalization could be used as a signature to distinguish 
MDR tumour cells from their drug-sensitive counterparts.  
Single cell population analysis, performed by a new multiparametric approach  
revealed a different patterns in the maps of Mg2+ concentration of the two 
cellular strains. In particular, LoVo-R cells present higher values within the 
nucleus in and in the perinuclear region respect to LoVo-S cells.  
Interestingly, perinuclear region of the cells is very rich in mitochondria 
organelles. The mitochondria located in this area form a barrier, named 
perinuclear mitochondria, for which it has been hypothezed a protecting role in 
defending nucleus against invasion of intracellular Ca2+ signals153. 
On these bases, the implication of this different distribution of Mg2+ in MDR 
cells could be related to the regulation of the energetics of nuclear transport and 
in triggering release of activators of apoptosis from perinuclear mitochondria. 
Furthermore, live cells loaded with DCHQ5 chemosensor showed higher Mg2+ 
levels in LoVo resistance colon cancer cells. This result was then confirmed, 
quantifying intracellular Mg2+ by DCHQ5 chemosensor in sonicated large cell 
population finding higher Mg2+ concentration in LoVo-R cells respect to LoVo-S. 
This latter result is coherently with that obtained by XRFM-AFM analysis in 
whole single cells revealing higher Mg2+ concentration in cells presenting MDR 
phenotype. 
It must be emphasized that, although the approaches used to quantify Mg2+ 
intracellular concentration were profoundly different, the average intracellular 
Mg2+ concentration found in a population of 10^5 cells assessed by DCHQ5-
assisted fluorimetric assay is of the same order of magnitude of that found in a 
sample of about 27 single cells  by XRFM-AFM analysis. This is not a trivial 
result, since recent studies on single-cell analysis drew attention to the problem 
of cell heterogeneity in large population. To this extent, a very recent study 
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showed a difference of two orders of magnitude in the concentration of 
intracellular TiO2-nanoparticles assessed in single cells or in cell population.154 
This feature open a new scenario in the significance of Mg2+ in cancer and in 
characteristic of cells developed MDR phenotype. 
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